Everyday Health (EVDY) 10-K 5 Mar 15 2014 FY Annual report Financial data

Document_And_Entity_Informatio

Document And Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Feb. 27, 2015	Feb. 23, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	Everyday Health, Inc.
Document Type	10-K
Current Fiscal Year End Date	-19
Entity Common Stock, Shares Outstanding		31,526,949
Entity Public Float			$0
Amendment Flag	FALSE
Entity Central Index Key	1358483
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Non-accelerated Filer
Entity Well-known Seasoned Issuer	No
Document Period End Date	31-Dec-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Current assets:
Cash and cash equivalents	$50,729	$16,242
Accounts receivable, net of allowance for doubtful accounts of $637 and $530 as of December 31, 2014 and 2013, respectively	68,007	49,373
Deferred tax asset	656	133
Prepaid expenses and other current assets	5,529	7,822
Total current assets	124,921	73,570
Property and equipment, net	25,502	21,095
Goodwill	127,115	82,153
Intangible assets, net	30,716	9,735
Other assets	5,237	5,729
Total assets	313,491	192,282
Current liabilities:
Accounts payable and accrued expenses	31,722	34,378
Deferred revenue	6,740	6,808
Current portion of long-term debt	3,000	1,333
Other current liabilities	965	830
Total current liabilities	42,427	43,349
Long-term debt	87,000	70,000
Deferred tax liabilities	6,673	5,199
Other long-term liabilities	4,105	4,937
Redeemable convertible preferred stock (Series A-G), net of expenses, $0.01 par value: 10,000,000 and 27,204,144 shares authorized at December 31, 2014 and 2013, respectively; no shares and 26,820,270 shares issued and outstanding at December 31, 2014 and 2013, respectively		158,766
Stockholders’ equity (deficit):
Common stock, $0.01 par value: 90,000,000 and 45,000,000 shares authorized at December 31, 2014 and 2013, respectively; 31,489,196 and 5,366,478 shares issued and outstanding at December 31, 2014 and 2013, respectively	314	54
Treasury stock	-55	-55
Additional paid-in capital	292,117	33,726
Accumulated deficit	-119,090	-123,694
Total stockholders’ equity (deficit)	173,286	-89,969
Total liabilities, redeemable convertible preferred stock and stockholders’ equity (deficit)	$313,491	$192,282

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parentheticals) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified
Allowance for doubtful accounts (in Dollars)	$637	$530
Preferred stock, par value (in Dollars per share)	$0.01	$0.01
Preferred stock, shares authorized	10,000,000	27,204,144
Preferred stock, shares issued	0	26,820,270
Preferred stock, shares outstanding	0	26,820,270
Common stock, par value (in Dollars per share)	$0.01	$0.01
Common stock, shares issued	31,489,196	5,366,478
Common stock, shares outstanding	31,489,196	5,366,478
Common stock, shares authorized	90,000,000	45,000,000

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Revenues
Advertising and sponsorship revenues	$166,465	$134,893	$109,956
Premium services revenues	17,860	20,957	23,536
Video production fees			5,000
Total revenues	184,325	155,850	138,492
Operating expenses:
Cost of revenues	49,296	43,338	40,543
Sales and marketing	48,605	44,385	38,603
Product development	44,541	43,759	45,676
General and administrative	30,041	27,462	25,874
Total operating expenses	172,483	158,944	150,696
Income (loss) from operations	11,842	-3,094	-12,204
Interest expense, net	-3,711	-8,442	-4,898
Other expense	-4,114	-359	-1,069
Income (loss) from continuing operations before provision for income taxes	4,017	-11,895	-18,171
Benefit (provision) for income taxes	8,666	-1,102	-1,026
Income (loss) from continuing operations	12,683	-12,997	-19,197
Loss from discontinued operations, net of tax		-5,239	-3,257
Net income (loss)	12,683	-18,236	-22,454
Series G preferred stock deemed dividend	-8,079
Net income (loss) attributable to common stockholders	$4,604	($18,236)	($22,454)
Basic net income (loss) attributable to common stockholders per common share:
Net income (loss) attributable to common stockholders from continuing operations (in Dollars per share)	$0.19	($2.55)	($4.01)
Net loss attributable to common stockholders from discontinued operations, net of tax (in Dollars per share)		($1.03)	($0.68)
Net income (loss) attributable to common stockholders (in Dollars per share)	$0.19	($3.57)	($4.69)
Diluted net income (loss) attributable to common stockholders per common share:
Net income (loss) attributable to common stockholders from continuing operations (in Dollars per share)	$0.17	($2.55)	($4.01)
Net loss attributable to common stockholders from discontinued operations, net of tax (in Dollars per share)		($1.03)	($0.68)
Net income (loss) attributable to common stockholders (in Dollars per share)	$0.17	($3.57)	($4.69)
Basic (in Shares)	24,259,395	5,103,351	4,791,474
Diluted (in Shares)	26,911,782	5,103,351	4,791,474

Consolidated_Statements_of_Red

Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (USD $)	Redeemable Convertible Preferred Stock [Member]	Common Stock [Member]	Common Stock [Member]	Treasury Stock [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	IPO [Member]	Total
In Thousands, except Share data		IPO [Member]			IPO [Member]
Balance at Dec. 31, 2011	$158,766		$47			$18,831	($83,004)		($64,126)
Balance (in Shares) at Dec. 31, 2011	26,820,270		4,709,010
Exercise of stock options			1			167			168
Exercise of stock options (in Shares)			46,505
Warrant issued in connection with credit facility						3,452			3,452
Issuance of common stock			1			699			700
Issuance of common stock (in Shares)			105,340
Stock-based compensation expense related to employee stock options						3,610			3,610
Net loss							-22,454		-22,454
Balance at Dec. 31, 2012	158,766		49			26,759	-105,458		-78,650
Balance (in Shares) at Dec. 31, 2012	26,820,270		4,860,855
Exercise of stock options			2			787			789
Exercise of stock options (in Shares)			183,501
Warrant issued in connection with credit facility						149			149
Issuance of common stock			3			2,992			2,995
Issuance of common stock (in Shares)			330,022
Purchase of treasury stock				-55					-55
Purchase of treasury stock (in Shares)			-7,900
Stock-based compensation expense related to employee stock options						3,039			3,039
Net loss							-18,236		-18,236
Balance at Dec. 31, 2013	158,766		54	-55		33,726	-123,694		-89,969
Balance (in Shares) at Dec. 31, 2013	26,820,270		5,366,478
Exercise of stock options			11			7,291			7,302
Exercise of stock options (in Shares)			1,139,891
Issuance of common stock for acquired business			1			918			919
Issuance of common stock for acquired business (in Shares)			65,710
Issuance of common stock in connection with employee stock purchase plan			1			1,591			1,592
Issuance of common stock in connection with employee stock purchase plan (in Shares)			138,184
Issuance of common stock		57			70,565			70,622
Issuance of common stock (in Shares)		5,676,414
Conversion of preferred stock	-158,766		184			158,582			158,766
Conversion of preferred stock (in Shares)	-26,820,270		18,457,235
Series G preferred stock deemed dividend						8,079	-8,079		-8,079
Reclassification of liability warrants to equity warrants						1,140		1,140	1,140
Exercise of warrants			6			-6
Exercise of warrants (in Shares)			645,284
Stock-based compensation expense related to employee stock options						9,100			9,100
Warrant issued in connection with website partner agreement						1,131			1,131
Net loss							12,683		12,683
Balance at Dec. 31, 2014			$314	($55)		$292,117	($119,090)		$173,286
Balance (in Shares) at Dec. 31, 2014			31,489,196

Consolidated_Statements_of_Red1

Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parentheticals) (IPO [Member], USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014
IPO [Member]
Issuance costs in connection with IPO	$8,848

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities
Net income (loss)	$12,683	($18,236)	($22,454)
Less loss from discontinued operations, net of tax		-5,239	-3,257
Income (loss) from continuing operations	12,683	-12,997	-19,197
Depreciation and amortization	14,943	15,450	14,602
Amortization of video and television costs		632	6,430
Provision for doubtful accounts	315	62	69
Stock-based compensation	9,100	2,969	3,532
Amortization and write-off of deferred financing costs	4,389	1,646	1,756
Loss on disposals of property and equipment		1,261
(Benefit) provision for deferred income taxes	-9,071	962	931
Accounts receivable	-12,437	-10,683	-3,200
Prepaid expenses and other current assets	1,489	-2,725	-246
Additions to video and television costs		-453	-5,876
Accounts payable and accrued expenses	-1,942	7,529	-28
Deferred revenue	-68	1,744	-5,171
Other current liabilities	58	-426	171
Other long-term liabilities	581	951	364
Net cash provided by (used in) operating activities from continuing operations	20,040	5,922	-5,863
Net cash used in operating activities from discontinued operations		-4,250	-2,919
Net cash provided by (used in) operating activities	20,040	1,672	-8,782
Cash flows from investing activities
Additions to property and equipment, net	-14,754	-10,654	-12,909
Proceeds from sale of business	400	600
Payment for business purchased, net of cash acquired	-65,000	-6,736	-2,627
Payment of security deposits and other assets	131	-717	4
Net cash used in investing activities	-79,223	-17,507	-15,532
Cash flows from financing activities
Net proceeds from common stock issuance	70,622
Proceeds from the exercise of stock options	7,939	101	168
Principal payments on capital lease obligations	-659	-456	-86
Payments of credit facility financing costs	-2,899	-68	-1,345
Payment for purchase of treasury stock		-55
Net cash provided by financing activities	93,670	8,189	20,964
Net increase (decrease) in cash and cash equivalents	34,487	-7,646	-3,350
Cash and cash equivalents, beginning of year	16,242	23,888	27,238
Cash and cash equivalents, end of year	50,729	16,242	23,888
Former Revolving Credit Facility [Member]
Cash flows from financing activities
Repayments of principal	-30,000	-850	-1,500
Borrowings		7,350	6,560
Former Term Loan [Member]
Cash flows from financing activities
Repayments of principal	-41,333	-2,833	-17,833
Borrowings		5,000	35,000
Revolving Credit Facility [Member]
Cash flows from financing activities
Repayments of principal	-32,300
Borrowings	62,300
Term Loan Facility [Member]
Cash flows from financing activities
Repayments of principal	-1,000
Borrowings	$61,000

Business

Business	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block [Abstract]
Business Description and Basis of Presentation [Text Block]	1. Business
	Everyday Health, Inc. (the “Company”) operates a portfolio of health and wellness websites and mobile applications that provides consumers, healthcare professionals, advertisers and partners with content and advertising-based services. The Company was incorporated in the State of Delaware in January 2002 as Agora Media Inc., and changed its name to Waterfront Media Inc. in January 2004. In January 2010, the Company changed its name to Everyday Health, Inc. to better align its corporate identity with the Everyday Health brand.

Significant_Accounting_Policie

Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	2. Significant Accounting Policies
	Principles of Consolidation
	The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. The results of operations for companies acquired are included in the consolidated financial statements from the effective date of the acquisition. All significant intercompany accounts and transactions have been eliminated in consolidation.
	Use of Estimates
	The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on historical experience, current business factors and other available information. Actual results could differ from those estimates. On an ongoing basis, the Company evaluates its estimates and assumptions, including those related to revenue recognition and deferred revenue, allowance for doubtful accounts, internal software development costs and website development costs, valuation of long-lived assets, goodwill and other intangible assets, income taxes and stock-based compensation.
	Reclassifications
	Certain reclassifications have been made to the prior year financial statements to conform to the December 31, 2014 presentation.
	Initial Public Offering
	On April 2, 2014, the Company closed its initial public offering of common stock (“IPO”). The IPO, including the additional shares issued and sold on April 30, 2014 pursuant to the underwriters’ exercise of their over-allotment option, resulted in net proceeds of $70,622, after deducting underwriting discounts and commissions and offering costs borne by the Company totaling $8,848. As a result of the IPO, the Company’s common stock, redeemable convertible preferred stock, additional paid-in capital, and stock options and warrants to purchase stock changed as follows (collectively, the “IPO- Related Transactions”): (i) the Company issued and sold 5,676,414 shares of common stock at a public offering price of $14.00 per share, (ii) all of the Company’s redeemable convertible preferred stock outstanding automatically converted into an aggregate of 18,457,235 shares of common stock, including 577,055 additional shares of common stock related to the Series G redeemable convertible preferred stock ratchet provision (refer to Note 10), (iii) certain selling stockholders exercised stock options and warrants for an aggregate of 339,053 shares of common stock, (iv) 149,839 shares of common stock were issued upon the automatic net exercise of a warrant, and (v) outstanding warrants to purchase 222,977 shares of redeemable convertible preferred stock automatically converted into warrants to purchase an aggregate of 148,650 shares of common stock, which resulted in the reclassification of the preferred stock warrant liability of $1,140 to additional paid-in capital.
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with original maturities of three months or less when purchased to be cash equivalents. Cash equivalents principally consist of the Company’s investment in U.S. Treasury securities and other money market funds. The fair value of these investment funds is based on quoted market prices, which are Level 1 inputs, pursuant to the fair value accounting standard, which establishes a framework for measuring fair value and requires disclosures about fair value measurements by establishing a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value.
	Property and Equipment
	Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, ranging from three to five years. Amortization of leasehold improvements is computed using the straight-line method over the shorter of the lease term or the estimated useful life of the improvement.
	Video and Television Costs
	The Company entered into agreements during 2011 and 2012 for the creation and production of a health/wellness television series, a recipe/food television series and a YouTube health channel. Video and television costs related to these productions are stated at the lower of cost, less accumulated amortization, or fair value in the consolidated balance sheets. The amount of capitalized video and television costs recognized in operating expense for a given period is determined using the film forecast computation method. Under this method, the amortization of capitalized costs is based on the proportion of the production’s revenues recognized for such period to the production’s estimated remaining ultimate revenues. All video and television costs relating to these productions were fully amortized as of December 31, 2013. Amortization expense of video and television costs, aggregating $632 and $6,430 for the years ended December 31, 2013 and 2012, respectively, is included in product development expense in the consolidated statements of operations.
	Internal Software Development Costs
	The Company incurs costs to develop software for internal use. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the application development phase, consisting principally of payroll and related benefits, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years.
	Website Development Costs
	The Company incurs costs to develop its website applications. The Company expenses all costs that relate to the planning and post-implementation phases of website development as product development expense. Costs incurred in the application development phase, consisting principally of third-party consultants and related charges, and the costs of content determined to provide a future economic benefit, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years.
	Goodwill
	Goodwill represents the excess cost over fair value of the identifiable net assets of acquired businesses.
	Goodwill is tested for impairment on an annual basis as of October 1, and whenever events or circumstances indicate that the carrying value of the asset may not be recoverable.
	An initial qualitative analysis is performed evaluating whether any events and circumstances occurred or exist that provide evidence that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, based on this analysis, indicators deem it more likely than not that the fair value of the reporting unit is less than its carrying amount, then the two-step quantitative impairment test is performed; otherwise, no further step is required.
	If and when needed to complete the two-step quantitative assessment, the fair value of goodwill is estimated using a combination of an income approach based on the present value of estimated future cash flows, and a market approach examining transactions in the marketplace involving the sale of stocks of similar publicly traded companies, or the sale of entire companies engaged in operations similar to those of the Company. As the Company has one operating segment and one reporting unit, the first step of the impairment test requires a comparison of the fair value of the reporting unit, or business enterprise value as a whole, to the carrying value of the Company’s invested capital. If the carrying amount exceeds the fair value, there is indication that an impairment may exist, and a second step must be performed. If the carrying amount is less than the fair value, no indication of impairment exists, and a second step is not performed.
	The evaluation of the Company’s goodwill indicated that the carrying value of the asset was less than the fair value and, accordingly, there was no impairment loss recognized for the years ended December 31, 2014, 2013 and 2012.
	Long-Lived Assets
	The Company reviews long-lived assets, including property and equipment and intangible assets with definite lives, for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. The intangible assets with definite lives consist principally of trade names, customer relationships and agreements with certain of the Company’s website partners. Definite-lived intangible assets are amortized over their estimated useful lives, ranging from three to ten years, using the straight-line method which approximates the pattern in which economic benefits are consumed. In accordance with its policy, the Company reviews the estimated useful lives of its intangible assets on an ongoing basis. There were no indicators of impairment of the Company’s long-lived assets during the year ended December 31, 2014. During the year ended December 31, 2013, the Company recorded impairment charges of $1,190 related to the consolidation and reorganization of certain website content and tools. This $1,190 charge is included in product development expense in the accompanying consolidated statements of operations. There were no indicators of impairment of the Company’s long-lived assets during the year ended December 31, 2012.
	Revenue Recognition and Deferred Revenue
	The Company generates its revenue from advertising and sponsorships, premium services, including subscriptions and licensing fees, and, to a lesser extent, video production fees. Advertising revenue is recognized in the period in which the advertisement is delivered. Revenue from sponsorships is recognized over the period the Company substantially satisfies its contractual obligations as required under the respective sponsorship agreements. When contractual arrangements contain multiple elements, revenue is allocated to each element based on its relative fair value determined using prices charged when elements are sold separately. In instances where individual deliverables are not sold separately, or when third-party evidence is not available, fair value is determined based on management’s best estimate of selling price.
	Subscriptions are generally paid in advance on a monthly, quarterly or annual basis. Subscription revenue, after deducting refunds and charge-backs, is recognized on a straight-line basis ratably over the subscription periods. Licensing revenue is generally recognized over the life of the contract. Video production fee revenue is recognized as the video content is completed and delivered to the customer.
	Deferred revenue relates to: (i) subscription fees for which amounts have been collected but for which revenue has not been recognized, and (ii) advertising and sponsorship fees and licensing fees billed in advance of when the revenue is to be earned.
	Cost of Revenues
	Cost of revenues consists principally of the expenses associated with aggregating the total audience across the Company’s portfolio of websites, including (i) royalty expenses for licensing content for certain websites within the portfolio and for the portion of advertising revenue the Company pays to the owners of certain other websites within the portfolio, and (ii) media costs associated with audience aggregation activities. Cost of revenues also includes credit card fees and service charges associated with subscription fees for the Company’s premium services.
	Royalty expense amounted to $20,937, $18,673 and $12,898 for the years ended December 31, 2014, 2013 and 2012, respectively.
	Media costs consist primarily of fees paid to online publishers, Internet search companies and other media channels for search engine and database marketing, and display and television advertising. These media activities are attributable to revenue-generating and audience aggregation events, designed to increase the audience to the websites the Company operates, increase the number of subscribers to premium services and grow the Company’s registered user base. Media costs totaled $24,973, $22,437 and $23,841 for the years ended December 31, 2014, 2013 and 2012, respectively.
	Other Expense
	In connection with the refinancing of its credit facilities in 2014, the Company wrote-off unamortized deferred financing costs totaling $2,845 and incurred prepayment fees of $1,016, which, together with the mark-to-market adjustment on certain preferred stock warrants of $253, is reflected as other expense in the accompanying consolidated statements of operations for the year ended December 31, 2014. In connection with the refinancing of its credit facilities in 2012, the Company wrote-off unamortized deferred financing costs totaling $1,069, which is reflected as other expense in the accompanying consolidated statements of operations for the year ended December 31, 2012.
	Income Taxes
	The Company accounts for taxes under the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the tax and financial statement reporting basis of assets and liabilities.
	Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company reduces the measurement of a deferred tax asset, if necessary, by a valuation allowance if it is more likely than not that the Company will not realize some or all of the deferred tax asset. As a result of the Company’s historical operating performance and the cumulative net losses incurred to date, the Company does not have sufficient objective evidence to support the recovery of the net deferred tax assets. Accordingly, the Company has established a valuation allowance against net deferred tax assets for financial reporting purposes to the extent it is determined that such deferred tax assets are not more likely than not to be realized.
	The Company accounts for uncertain tax positions by recognizing the financial statement effects of a tax position only when, based upon technical merits, it is “more likely than not” that the position will be sustained upon examination. Potential interest and penalties associated with unrecognized tax positions are recognized in income tax expense.
	Comprehensive Income (Loss)
	Other than the Series G preferred stock deemed dividend reflected in the accompanying statement of operations for the year end December 31, 2014 (see Note 10), the Company has no items of other comprehensive income (loss).
	Fair Value of Financial Instruments
	Due to their short-term maturities, the carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximate fair value. Cash equivalents principally consist of the Company’s investment in U.S. Treasury securities and other highly liquid money market funds. The fair value of these investment funds is based on quoted market prices, which are Level 1 inputs, pursuant to the fair value accounting standard, which establishes a framework for measuring fair value and requires disclosures about fair value measurements by establishing a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The fair value of the Company’s debt approximates the recorded amounts as the interest rates on the credit facilities are based on market interest rates.
	Stock-Based Compensation
	The Company accounts for all share-based payments, including grants of employee stock options, based on the fair value of the award measured at the grant date. The Company uses the Black-Scholes option pricing model to estimate the fair value of the stock option awards. Stock-based compensation expense is recognized over the period during which the recipient provides services, generally the vesting period.
	Business Concentrations, Accounts Receivable and Credit Risk
	Financial instruments which potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents and accounts receivable.
	Cash and cash equivalents includes U.S. Treasury securities and other money market funds.
	Concentration of credit risk with respect to accounts receivable is limited due to the large number of customers comprising the Company’s customer base and the ongoing credit evaluation of its customers.
	For the year ended December 31, 2014, no advertising customer accounted for greater than 10% of total revenues. For the year ended December 31, 2013, one advertising customer accounted for 12% of total revenues. For the year ended December 31, 2012, no advertising customer accounted for greater than 10% of total revenues. As of December 31, 2014, no advertising customers accounted for greater than 10% of total accounts receivable. As of December 31, 2013, one advertising customer accounted for 16% of accounts receivable. As many of the Company’s advertising customers work through the same advertising agencies, the Company also monitors the concentration of accounts receivable at the agency level. As of December 31, 2014, no advertising agency accounted for greater than 10% of accounts receivable. As of December 31, 2013, three advertising agencies accounted for 14%, 11% and 11% of accounts receivable, respectively.
	The Company’s accounts receivable balance of $68,007 and $49,373 reflected in the accompanying balance sheets as of December 31, 2014 and 2013, respectively, include unbilled accounts receivable of $7,064 as of December 31, 2014 and $290 as of December 31, 2013. The $7,064 consists of $4,482 of unbilled accounts receivable relating to DoctorDirectory.com, Inc. contracts (see Note 3) for which billings were not issued as of December 31, 2014, and $2,582 of revenue earned on the Company’s advertising and sponsorship contracts which were not contractually billable as of such date.
	An allowance for doubtful accounts is established with respect to accounts receivable that the Company has determined to be doubtful of collection, based upon factors surrounding the credit risk of customers, historical experience and other information.
	The following table summarizes the activity of the allowance for doubtful accounts:
			Year Ended December 31,
			2014				2013				2012
	Balance at beginning of year			$	530			$	651			$	835
	Bad debt provision				384				251				501
	Write-offs				(277	)			(372	)			(685	)
	Balance at end of year			$	637			$	530			$	651
	Business Combinations
	The Company allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. Such valuations require management to make significant estimates and assumptions, especially with respect to intangible assets. During the measurement period, which is up to one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed, based on additional information impacting the assigned estimated fair values.
	Segment Information
The Company and its subsidiaries are organized in a single operating segment, providing online health solutions, and the Company also has one reportable segment. Substantially all of the Company’s revenues are derived from U.S. sources.
Net Income (Loss) Attributable to Common Stockholders per Common Share
Basic net income (loss) attributable to common stockholders per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period.
Diluted net income (loss) attributable to common stockholders per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period, adjusted to reflect potentially dilutive securities. Potentially dilutive securities consist of incremental shares issuable upon the assumed exercise of stock options and warrants using the treasury stock method, convertible preferred shares using the “if-converted” method, and employee withholdings to purchase common stock under the Company’s 2014 Employee Stock Purchase Plan, or ESPP. For the years ended December 31, 2013 and 2012, the Company had outstanding options, warrants and convertible preferred stock which were not included in the computation of diluted net loss per common share because the effect would have been anti-dilutive.
The basic and diluted net income (loss) attributable to common stockholders per common share is calculated as follows for the periods presented:
		Year Ended December 31,
		2014				2013				2012
Numerator:
Income (loss) from continuing operations			$	12,683			$	(12,997	)		$	(19,197	)
Loss from discontinued operations, net of tax				—				(5,239	)			(3,257	)
Net income (loss)				12,683				(18,236	)			(22,454	)
Series G preferred stock deemed dividend				(8,079	)			—				—
Net income (loss) attributable to common stockholders			$	4,604			$	(18,236	)		$	(22,454	)
Denominator:
Weighted-average number of common shares outstanding for basic net income (loss) attributable to common stockholders per common share				24,259,395				5,103,351				4,791,474
Dilutive securities:
Stock option awards (1)				2,235,059				—				—
Warrants to purchase common stock				412,305				—				—
Employee stock purchase plan				5,023				—				—
Total weighted-average diluted shares				26,911,782				5,103,351				4,791,474
Basic net income (loss) attributable to common stockholders per common share:
Income (loss) from continuing operations			$	0.19			$	(2.55	)		$	(4.01	)
Loss from discontinued operations, net of tax				—				(1.03	)			(0.68	)
Net income (loss) attributable to common stockholders			$	0.19			$	(3.57	)		$	(4.69	)
Diluted net income (loss) attributable to common stockholders per common share:
Income (loss) from continuing operations			$	0.17			$	(2.55	)		$	(4.01	)
Loss from discontinued operations, net of tax				—				(1.03	)			(0.68	)
Net income (loss) attributable to common stockholders			$	0.17			$	(3.57	)		$	(4.69	)
	-1		The weighted-average diluted shares for the year ended December 31, 2014 excludes a weighted-average number of stock options of 1,337,766 which were anti-dilutive.
Foreign Currency
The financial statements and transactions of the Company’s foreign subsidiary are maintained in its local currency. The translation of foreign currencies into United States dollars is performed for balance sheet accounts using current exchange rates in effect at the balance sheet date, and for revenue and expense accounts using average exchange rates during the year. Foreign currency gains or losses are included in the consolidated statements of operations and were not material in any of the periods presented.
Recently Issued and Adopted Accounting Standards
In July 2013, the Financial Accounting Standards Board (“FASB”) issued amended guidance for income taxes. This amendment requires that entities present an unrecognized tax benefit, or portion of an unrecognized tax benefit, as a reduction to a deferred tax asset in the financial statements for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, with certain exceptions. The Company adopted this amended guidance beginning in the quarter ended March 31, 2014. The adoption of this guidance had no impact on the Company’s consolidated financial statements.
In April 2014, the FASB issued amended guidance for reporting discontinued operations. Under the new guidance, only disposals that represent a strategic shift having a material impact on an entity’s operations and financial results shall be reported as discontinued operations, with expanded disclosures. This amendment will be effective for the first annual reporting period beginning after December 15, 2015. The Company does not expect the impact of the adoption of this guidance to be material to the consolidated financial statements.
In May 2014, the FASB issued amended guidance for revenue recognition. This amendment provides a comprehensive new revenue recognition model. The core principle of the guidance is to recognize revenue when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. This amendment is effective for fiscal years beginning after December 15, 2016, and for interim periods within those fiscal years. Early adoption is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. The Company has not yet selected a transition method and is currently evaluating the effect that the new standard will have on the consolidated financial statements and related disclosures.
In June 2014, the FASB issued updated guidance on stock compensation accounting requiring that a performance target that affects vesting and could be achieved after the requisite service period should be treated as a performance condition. Current GAAP does not contain explicit guidance on how to account for such share-based payments. This updated guidance is effective for fiscal years beginning after December 15, 2015, and for interim periods within those fiscal years. Early adoption is permitted. The Company does not expect the impact of the adoption of this guidance to be material to the consolidated financial statements.

Acquisitions

Acquisitions	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block Supplement [Abstract]
Mergers, Acquisitions and Dispositions Disclosures [Text Block]	3. Acquisitions
	In November 2014, the Company acquired all of the outstanding equity of DoctorDirectory.com, Inc., a South Carolina corporation (“DD”), which provided pharmaceutical companies with multi-channel interactive marketing services that target healthcare professionals, for a cash purchase price of $65,000. The Company expects that the DD acquisition will enable the Company to significantly increase the number of healthcare professionals it reaches, deepen and broaden its relationships with pharmaceutical companies, gain valuable expertise across sales, marketing and data and analytics, and introduce new products and services to healthcare professionals. As of December 31, 2014, all purchase price obligations were settled, subject to any working capital adjustments that may arise.
	For the year ended December 31, 2014, acquisition-related costs of $183 are included in general and administrative expenses in the accompanying consolidated statement of operations. The acquisition was accounted for as a business combination and, accordingly, the purchase price was allocated to the tangible and intangible assets acquired and liabilities assumed on the basis of their respective fair values. The results of operations of DD have been included in the consolidated financial statements of the Company from November 12, 2014, the closing date of the acquisition.
	The following table summarizes the preliminary allocation of the assets acquired and liabilities assumed based on their fair values on the acquisition date. The fair values presented are based on a preliminary valuation and are subject to adjustment during a measurement period of up to one year from the acquisition date. The measurement period provides the Company with the ability to adjust the fair values of acquired assets for new information that is obtained about circumstances that existed as of the acquisition date.
	Accounts receivable		$	6,513
	Deferred tax asset			81
	Other current assets			232
	Property and equipment			1,612
	Goodwill			44,962
	Intangible assets			23,500
	Accounts payable and accrued expenses			(1,798	)
	Deferred tax liability			(10,102	)
	Total consideration paid		$	65,000
	The following table presents the Company’s pro forma consolidated revenues and net income (loss) for the years ended December 31, 2014 and 2013. The unaudited pro forma results include the historical consolidated statements of operations of the Company and DD, giving effect to the DD acquisition, and related financing transactions, as if they had occurred at the beginning of the earliest period presented.
		Unaudited
		Pro Forma Results
		Year Ended December 31,
		2014				2013
	Revenues		$	201,335			$	172,877
	Net income (loss)		$	4,640			$	(12,425	)
	The unaudited pro forma results include: (i) amortization expense associated with acquired intangible and technology assets; (ii) incremental interest expense related to additional borrowings on the Company’s Credit Facility in connection with financing the DD acquisition, and amortization of related deferred financing costs (see Note 9); (iii) elimination of stock-based compensation expenses related to the pre-acquisition period; (iv) elimination of transaction costs incurred related to the acquisition; and (v) elimination of DD’s historical federal tax provision for the year ended December 31, 2013, as the combined entity would have a loss before provision for income taxes for the year. Additionally, the unaudited pro forma combined net income for the year ended December 31, 2014 includes a pro forma adjustment to eliminate a one-time benefit recorded to the provision for income taxes of $10,033 (see Note 12) which resulted from reducing the deferred tax valuation allowance related to acquired intangible and other assets. The benefit is excluded from the unaudited pro forma results as it will not have a continuing impact on the combined results.
	The unaudited pro forma results give effect to pro forma events that are (1) directly attributable to the assumed acquisition, (2) factually supportable, and (3) with respect to the combined statements of operations, expected to have a continuing impact on the combined results. Additionally, the unaudited pro forma adjustments are not necessarily indicative of or intended to represent the results that would have been achieved had the transaction been consummated as of the date indicated or that may be achieved in the future. The actual results reported by the combined company in periods following the acquisition may differ significantly from those reflected in the pro forma results for a number of reasons, including cost saving synergies from operating efficiencies and the effect of the incremental costs incurred to integrate the two companies.
	In September 2012, the Company acquired all of the outstanding equity of EQAL, Inc., a Delaware corporation (“EQ”), which managed digital media properties for various brands and celebrities. The EQ acquisition enabled the Company to expand its core lifestyle offerings by exploiting EQ’s expertise in branded digital content, scripted video, social marketing and celebrity influence. The purchase price was valued at $9,657, consisting of $6,736 in cash and shares of common stock valued at $2,921. The cash and stock amounts due to the former EQ stockholders were payable in installments during 2013. As of December 31, 2013, all such purchase price obligations were settled.
	For the year ended December 31, 2012, acquisition-related costs of $89 are included in general and administrative expenses in the accompanying consolidated statement of operations. The acquisition was accounted for as a business combination and, accordingly, the purchase price was allocated to the tangible and intangible assets acquired and liabilities assumed on the basis of their respective fair values. The results of operations of EQ have been included in the consolidated financial statements of the Company from September 21, 2012, the closing date of the acquisition. Pro forma consolidated results of operations giving effect to this acquisition would not vary materially from historical results.
	The following table summarizes the tangible and intangible assets acquired, the liabilities assumed and the consideration paid:
	Cash		$	174
	Accounts receivable			1,167
	Other current assets			237
	Property and equipment			18
	Goodwill			9,904
	Intangible assets			1,130
	Other assets			26
	Accounts payable and accrued expenses			(1,819	)
	Deferred revenue			(625	)
	Other current liabilities			(555	)
	Total consideration paid		$	9,657
	During 2013, the merger agreement with EQ was amended with respect to the contingent earn-out provisions. Pursuant to the amendments, the former stockholders and founders of EQ were eligible to receive up to $5,000 based on the Company’s achievement of certain revenue and operating income targets during 2013. The Company records any such earn-outs as compensation expense for the applicable periods. For the year ended December 31, 2013, the Company incurred $2,211 of such expense, which is included in sales and marketing expense in the accompanying consolidated statements of operations. The earn-out payment, which was payable in cash and shares of the Company’s common stock, was settled in full during the year ended December 31, 2014.

Discontinued_Operations

Discontinued Operations	12 Months Ended
	Dec. 31, 2014
Discontinued Operations and Disposal Groups [Abstract]
Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]	4. Discontinued Operations
	In November 2013, the Board of Directors approved a plan to sell the Doctor Solutions business, which provided online directories and other marketing services to healthcare professionals. By the end of 2013, the Company identified a buyer and completed the sale, at a price of $1,000. The sale represented a disposal of a component of an entity whose operations and cash flows were eliminated from the Company’s ongoing business after the sale. As such, the operating results, along with the loss on sale, have been reported as discontinued operations in the consolidated statements of operations for the years ended December 31, 2013 and 2012. As the sale was completed during 2013, there were no results from discontinued operations to report for the year ended December 31, 2014. The loss from discontinued operations was comprised of the following:
		Year ended December 31,
		2013				2012
	Revenues		$	7,116			$	7,794
	Loss from operations		$	(3,971	)		$	(3,257	)
	Loss on sale			(1,268	)			—
	Loss from discontinued operations before tax			(5,239	)			(3,257	)
	Income tax (provision) benefit			—				—
	Net loss from discontinued operations		$	(5,239	)		$	(3,257	)
	No benefit for income taxes was provided as the Company recorded a full valuation allowance against the NOLs generated by the discontinued operations.

Prepaid_Expenses_and_Other_Cur

Prepaid Expenses and Other Current Assets	12 Months Ended
	Dec. 31, 2014
Prepaid Expenses And Other Current Assets [Abstract]
Prepaid Expenses And Other Current Assets [Text Block]	5. Prepaid Expenses and Other Current Assets
	Prepaid expenses and other current assets consist of the following:
		December 31,
		2014			2013
	Prepaid royalties		$	1,225		$	1,195
	Initial public offering costs			—			1,083
	Prepaid marketing			422			714
	Amount due from buyer of business			—			400
	Restricted cash			—			500
	Other			3,882			3,930
	Total		$	5,529		$	7,822

Property_and_Equipment

Property and Equipment	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	6. Property and Equipment
	Property and equipment consist of the following:
		December 31,
		2014				2013
	Computer equipment and purchased software		$	12,402			$	10,529
	Internally developed software			37,226				28,486
	Acquired technology			1,957				927
	Furniture, fixtures and office equipment			2,978				2,858
	Leasehold improvements			6,381				6,296
	Website development costs			25,292				20,425
				86,236				69,521
	Less accumulated depreciation and amortization			(60,734	)			(48,426	)
	Total		$	25,502			$	21,095
	During the years ended December 31, 2014, 2013 and 2012, the Company capitalized $8,870, $7,416 and $7,279, respectively, of internally developed software costs. Unamortized internally developed software was $13,078 and $10,882 as of December 31, 2014 and 2013, respectively. Amortization expense of internally developed software was $6,583, $5,198 and $4,196 for the years ended December 31, 2014, 2013 and 2012, respectively.
	Depreciation and amortization expense related to property and equipment is classified as follows in the accompanying consolidated statements of operations:
		Year Ended December 31,
		2014				2013				2012
	Sales and marketing		$	1,286			$	1,183			$	1,065
	Product development			10,811				10,325				9,324
	General and administrative			327				350				423
	Total depreciation and amortization		$	12,424			$	11,858			$	10,812

Goodwill_and_Other_Intangible_

Goodwill and Other Intangible Assets	12 Months Ended
	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets Disclosure [Text Block]	7. Goodwill and Other Intangible Assets
	During the year ended December 31, 2014, goodwill of $44,962 and definite-lived intangible assets of $23,500 were recorded in connection with the DD acquisition (see Note 3). Included in the goodwill is $10,033 recorded in connection with a deferred tax liability recognized upon acquisition, related to basis differences in acquired intangible assets (see Note 12). Intangible assets acquired in connection with the DD acquisition consist of customer relationships of $15,390 and trade names of $8,110, which have estimated useful lives of 10 years and 7 years, respectively.
	During the year ended December 31, 2013, goodwill increased by $321 during the subsequent measurement period from purchase price adjustments related to the EQ acquisition. In connection with the sale of the Doctor Solutions business in 2013, goodwill of $235 and intangible assets with an unamortized balance on the date of sale of $1,547 were written off as part of the loss on sale of discontinued operations (see Note 4).
	During the year ended December 31, 2012, goodwill of $9,583 and definite-lived intangible assets of $1,130 were recorded in connection with the EQ acquisition (see Note 3).
	Intangible assets consist of the following:
			31-Dec-14												31-Dec-13
			Gross			Accumulated				Net			Weighted-		Gross			Accumulated				Net			Weighted-
			carrying			amortization							average		carrying			amortization							average
			amount										remaining		amount										remaining
													useful												useful
													life(a)												life(a)
	Customer relationships			$	27,300		$	(11,247	)		$	16,053		9.5		$	11,910		$	(10,481	)		$	1,429		2.9
	Other intangibles				3,900			(3,482	)			418		0.7			3,900			(2,925	)			975		1.7
	Trade names				18,615			(4,370	)			14,245		6.5			10,505			(3,174	)			7,331		7
	Total			$	49,815		$	(19,099	)		$	30,716				$	26,315		$	(16,580	)		$	9,735
		(a)		The calculation of the weighted-average remaining useful life is based on weighting the net book value of each asset in its group, and applying the weight to its respective remaining amortization period.
	Amortization expense relating to the definite-lived intangible assets totaled $2,519, $3,592 and $3,790 for the years ended December 31, 2014, 2013 and 2012, respectively, and is included in general and administrative expense in the accompanying consolidated statements of operations.
	Future amortization expense of the intangible assets is estimated to be as follows:
	Year ending December 31:
	2015			$	4,635
	2016				3,945
	2017				3,937
	2018				3,748
	2019				3,748
	Thereafter				10,703
	Total			$	30,716

Accounts_Payable_and_Accrued_E

Accounts Payable and Accrued Expenses	12 Months Ended
	Dec. 31, 2014
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	8. Accounts Payable and Accrued Expenses
	Accounts payable and accrued expenses consist of the following:
		December 31,
		2014			2013
	Accounts payable		$	8,563		$	8,459
	Accrued compensation			8,260			8,282
	Accrued acquisition earn-outs			1,425			3,639
	Accrued royalties			5,991			6,589
	Accrued media and licensed content			3,716			3,178
	Accrued interest			408			943
	Accrued professional fees			718			872
	Other accrued expenses			2,641			2,416
	Total		$	31,722		$	34,378

LongTerm_Debt

Long-Term Debt	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block [Abstract]
Long-term Debt [Text Block]	9. Long-Term Debt
	The Company entered into a credit facility agreement with a syndicated bank group in March 2014, which replaced its then-existing credit facility as described further below. The credit facility consisted of a revolver (“Revolver”) with a maximum borrowing limit of $35,000 and a term loan (“Term Loan”) of $40,000. In November 2014, in connection with the DD acquisition (see Note 3), the credit facility was amended and restated (as amended and restated, the “Credit Facility”), which, among other things, (i) increased the maximum borrowing limit of the Revolver from $35,000 to $55,000; (ii) increased the Term Loan from $39,000 outstanding as of such date to $60,000; (iii) extended the maturity date of the Term Loan and the due date of principal on the Revolver from March 2019 to November 2019; and (iv) effected certain modifications to the covenants and terms as set forth in the Credit Facility agreement.
	The repayment terms of the Revolver provide for quarterly interest payments, with the principal being due in full in November 2019. The repayment terms of the Term Loan provide for quarterly interest and principal payments, with a maturity date of November 2019. The interest rate on the Credit Facility is equal to the London Inter-Bank Offered Rate, or LIBOR, plus a variable rate ranging from 2.75% to 4.0% depending on the Company’s consolidated leverage ratio, as defined in the Credit Facility agreement, and there is a 0.50% commitment fee on the unused portion of the Revolver. As of December 31, 2014, the interest rate on the Credit Facility was 3.48%. As of December 31, 2014, there was $60,000 outstanding on the Term Loan and $30,000 outstanding on the Revolver.
	The Credit Facility contains certain financial and operational covenants, including requirements to maintain a minimum consolidated fixed charge coverage ratio and a maximum consolidated leverage ratio, each as defined in the Credit Facility agreement, as well as restrictions on certain types of dispositions, mergers and acquisitions, indebtedness, investments, liens and capital expenditures, issuance of capital stock and the Company’s ability to pay dividends. The Credit Facility is secured by a first priority security interest in substantially all of the Company’s existing and future assets. The Company was in compliance with the financial and operational covenants of the Credit Facility as of December 31, 2014.
	Maturities of debt outstanding as of December 31, 2014 are as follows:
	2015	$	3,000
	2016		6,000
	2017		6,000
	2018		6,000
	2019		69,000
	Total	$	90,000
	In connection with the credit facility financing in March 2014 discussed above, the Company repaid all outstanding borrowings under its former credit facilities, and such credit facilities were terminated. In March 2014, the Company wrote-off unamortized deferred financing costs of $2,845 and prepayment fees of $1,016 related to the former credit facilities, which is reflected in other expense in the accompanying consolidated statement of operations for the year ended December 31, 2014.
	Prior to termination of the former credit facilities, the Company maintained a credit facility, which was entered into in September 2010 and was amended in 2011, 2012 and 2013. This former credit facility (as amended, the “Former Credit Facility”) consisted of a revolving facility and a term loan. Under the Former Credit Facility, the maximum amount that could be outstanding under the revolver was the lesser of $30,000 and 80% of eligible accounts receivable. The maximum amount that could be outstanding under the term loan was $8,500. The repayment terms of the revolver, as amended, provided for monthly interest payments, with the principal being due in September 2015. The repayment terms for the term loan, as amended, provided for monthly interest payments, with principal payments commencing in April 2011 and ending in December 2014.
	At December 31, 2013, the outstanding borrowings under the revolver and term loan components of the Former Credit Facility amounted to $30,000 and $1,333, respectively. At December 31, 2013, the interest rate on the revolver was Wall Street Journal Prime Rate (“WSJ Prime rate”) plus 2.0%, or 5.25%. At December 31, 2013, the interest rate on the term loan was the WSJ Prime rate plus 3.25%, or 6.50%.
	In addition to the Former Credit Facility, the Company also previously maintained a subordinated credit facility, consisting of a 54-month term loan (the “Initial Subordinated Facility”). Under the Initial Subordinated Facility, the maximum amount that could be outstanding was $15,000, and the interest rate was 13.0%. In October 2012, the Company entered into a new subordinated facility with the lender of the Former Credit Facility and an unrelated third party (the “Subordinated Facility”), and repaid all outstanding borrowings under the Initial Subordinated Facility, and such facility was terminated.
	The Subordinated Facility consisted of a 36-month $35,000 term loan. The repayment terms for the Subordinated Facility provided for monthly interest payments commencing in November 2012 and ending in November 2015. The principal amount was payable in full in October 2015. The interest rate for the Subordinated Facility was 14.0%.
	During the year ended December 31, 2013, the Company entered into a loan modification to the Subordinated Facility, which consisted of a $5,000 increase to the term loan, with such additional amount being payable in full in November 2016. At December 31, 2013, outstanding borrowings under the Subordinated Facility, as amended, amounted to $40,000.
	The Former Credit Facility and Subordinated Facility contained certain financial and operational covenants, including restrictions on certain types of dispositions, mergers and acquisitions, indebtedness, investments, liens and capital expenditures, issuance of capital stock and the ability of the Company to pay dividends and make other distributions. The Company was in compliance with the financial and operational covenants of the Former Credit Facility and Subordinated Facility as of December 31, 2013 and 2012.
	In connection with the credit facilities that were in place prior to 2014, the Company issued to the lenders warrants to purchase a total of: (i) 592,501 shares of common stock at $0.015 per share, (ii) 112,959 shares of Series F redeemable convertible preferred stock at $7.61 per share, and (iii) 110,018 shares of Series C redeemable convertible preferred stock at $3.27 per share. Each of the above warrants were immediately exercisable and, accordingly, the Company calculated the fair value of the warrants using the Black-Scholes option pricing model and recorded deferred financing costs related to the issuances of the warrants in the respective periods. In April 2014, in connection with the closing of the Company’s IPO, the above warrants to purchase 222,977 shares of preferred stock were converted into warrants to purchase an aggregate of 148,650 shares of common stock. This conversion resulted in the warrant liability of $1,140 being reclassified to additional paid-in capital.
	The Company incurred financing costs of $2,899, $68 and $1,345 during the years ended December 31, 2014, 2013 and 2012, respectively, which, along with the fair value of warrants, have been deferred and amortized using the effective interest rate method through the final maturities of the respective credit facilities. Deferred financing costs are recorded in other assets in the accompanying consolidated balance sheets. Amortization expense relating to the deferred financing costs was $528, $1,646 and $687 for the years ended December 31, 2014, 2013 and 2012, respectively, and is included in interest expense in the accompanying consolidated statements of operations.

Common_Stock_and_Redeemable_Co

Common Stock and Redeemable Convertible Preferred Stock	12 Months Ended
	Dec. 31, 2014
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	10. Common Stock and Redeemable Convertible Preferred Stock
	As of December 31, 2014 and 2013, respectively, there were no shares and 26,820,270 shares of redeemable convertible preferred stock issued and outstanding. The redeemable convertible preferred stock, Series A-G (collectively, the “Preferred Stock”), which was outstanding at the time of the Company’s IPO, fully converted to common stock in connection with the IPO (see Note 1). Such Preferred Stock had the following characteristics:
	Conversion
	Each share of Preferred Stock was convertible at the option of the holder, at any time, into such number of fully paid shares of the Company’s common stock equal to the applicable original issue price for such share of Preferred Stock divided by the applicable conversion price for such share of Preferred Stock then in effect. As of December 31, 2013, the original issue prices and the conversion prices for each series of Preferred Stock were as follows: $0.50 for Series A, $1.77 for Series B, $3.27 for Series C, $6.87 for Series D, $7.98 for Series E, $7.61 for Series F and $9.00 for Series G (prior to giving effect to a 1-for-1.5 reverse stock split of the Company’s common stock implemented on March 14, 2014 in connection with the IPO). The conversion prices for each series of Preferred Stock were subject to adjustment upon the occurrence of certain events, including stock dividends, stock splits, combinations or other similar recapitalizations, and issuance of capital stock at a price below the conversion price in effect for such series of redeemable convertible preferred stock. The conversion price for the Series G convertible preferred stock was also subject to further adjustment in the event of an IPO with a public offering price of less than $11.88 per share.
	Dividends
	The holders of Preferred Stock were entitled to receive, when and as declared by the Board of Directors and out of funds legally available, non-cumulative dividends at a rate determined by the Board of Directors, payable in preference and priority to the payment of any dividends on common stock. Through December 31, 2014, no dividends were declared or paid by the Company.
	Liquidation Preference
	In the event of any liquidation, dissolution or winding up of the Company, whether voluntary or involuntary, the holders of the then outstanding Preferred Stock would receive, in preference to any payments to the holders of common stock, an amount (i) for the Preferred Stock other than the Series G, equal to the original issue price for such series of Preferred Stock (except that the holders of Series E would receive $1.77 per share in lieu of the original issue price) plus all declared but unpaid dividends and (ii) for the Series G, equal to the original issue price for the Series G, plus an amount per share per annum equal to $0.90 compounded annually (subject to a maximum amount, including the original issue price for the Series G, equal to $12.15), plus all declared but unpaid dividends (“Preferential Payments”).
	After all Preferential Payments, the remaining assets of the Company would be distributed among the holders of the shares of Series A, Series C, Series D and common stock, pro rata, based on the number of shares held on an “as-if converted” basis (except that the holders of shares of Series C and Series D would not receive more than an aggregate of $6.54 and $10.30, respectively, including Preferential Payments).
	Voting
	Each holder of Preferred Stock was entitled to the number of votes equal to the number of shares of common stock into which such holder’s shares of Preferred Stock were convertible at the time of such vote and would vote together with the holders of common stock on any matters presented to the stockholders for their consideration. In addition, the holders of Preferred Stock were entitled to vote separately from the common stock to elect six members of the Board of Directors and to approve certain specified matters. On all matters in which the holders of Preferred Stock were entitled to vote separately, the holders of Series E could not cast more than 28.5% of the votes (the “Series E Reduced Voting”).
	Redemption
	Redemption rights issued in connection with the Series C were extended to the holders of the Series A and Series B in February 2006, with the right to require redemption commencing 60 days after receipt by the Company of a notice by the holders of Preferred Stock on or after February 2011. Redemption rights were also issued to the holders of the Series D, with the right to require redemption commencing 60 days after receipt by the Company of a notice by the holders of Preferred Stock on or after August 2012.
	Concurrent with the issuance of the Series D, the holders of the Series A, Series B and Series C agreed to modify their redemption rights so that the right to require redemption commenced 60 days after receipt by the Company of a notice by the holders of Preferred Stock on or after August 2012. Concurrent with the issuance of the Series F, the holders of Series A, Series B, Series C, Series D and Series E agreed to modify their redemption rights so that the right to require redemption required approval of at least 56% of the outstanding Preferred Stock (subject to the Series E Reduced Voting), commencing 60 days after receipt by the Company of a notice by the holders of Preferred Stock on or after October 15, 2013.
	Concurrent with the issuance of the Series G, (i) the holders of Series A, Series B, Series C, Series D, Series E and Series F agreed to modify their redemption rights so that the right to require redemption required approval of at least 56% of the outstanding Series A, Series B, Series C, Series D, Series E and Series F (subject to the Series E Reduced Voting), and (ii) the holders of a majority of the Series G were given the right to require redemption, in each case, commencing not less than 75 days and not more than 90 days (subject to certain modifications, as set forth in the Company’s certificate of incorporation) after receipt by the Company of a notice by such holders of Preferred Stock on or after November 10, 2016. Accordingly, (i) at the option of 56% of the holders of Series A, Series B, Series C, Series D, Series E and Series F (subject to the Series E Reduced Voting), each share of Series A, Series B, Series C, Series D, Series E and Series F became redeemable at a price equal to the applicable original issue price per such share of Preferred Stock, plus all declared but unpaid dividends thereon, commencing not less than 75 days and not more than 90 days (subject to certain modifications, as set forth in the Company’s certificate of incorporation) after receipt by the Company of a notice by the holders of such Preferred Stock on or after November 10, 2016, and (ii) at the option of a majority of the holders of Series G, each share of Series G became redeemable at a price equal to the applicable original issue price per share of Series G, plus all declared but unpaid dividends thereon, commencing not less than 75 days and not more than 90 days (subject to certain modifications, as set forth in the Company’s certificate of incorporation) after receipt by the Company of a notice by the holders of Series G on or after November 10, 2016. In addition, for as long as any share of Series G was not redeemed after the date on which the Company had the obligation to redeem such share, interest at the rate of 15% per annum would accrue on the redemption price of such share of Series G, which interest would be payable quarterly in arrears.
	The Company recorded its Preferred Stock outside of permanent equity because the redemption feature was not solely within the control of the Company.
	In March 2014, the Company’s Board of Directors and stockholders approved an amendment to the Company’s amended and restated certificate of incorporation effecting a 1-for-1.5 reverse stock split of the Company’s issued and outstanding shares of common stock. The par value of the common stock was not adjusted as a result of the reverse stock split. All issued and outstanding common stock and per share amounts contained in the Company’s consolidated financial statements and related notes thereto have been retroactively adjusted to reflect this reverse stock split for all periods presented. The reverse stock split was effected on March 14, 2014.
	In April 2014, in connection with the closing of the Company’s IPO, the Company filed an amended and restated certificate of incorporation with the Secretary of State of the State of Delaware that amended and restated in its entirety the Company’s certificate of incorporation to, among other things, increase the total number of shares of the Company’s common stock that the Company is authorized to issue to 90,000,000, eliminate all references to the various series of preferred stock that were previously authorized (including certain protective measures held by the various series of preferred stock), and to authorize up to 10,000,000 shares of undesignated preferred stock that may be issued from time to time with terms to be set by the Company’s Board of Directors, which rights could be senior to those of the Company’s common stock.
	In connection with the IPO, all of the Company’s redeemable convertible preferred stock converted into common shares, which is discussed below in further detail. There was no redeemable convertible preferred stock outstanding at December 31, 2014.
	The number of shares of the Company’s redeemable convertible preferred stock was not adjusted in connection with the 1-for-1.5 reverse stock split of common stock referred to above. The Company’s redeemable convertible preferred stock consisted of the following at December 31, 2013:
		Shares				Stated value,			Liquidation
		Authorized		Issued and		net of expenses			preference
				outstanding
	Redeemable convertible preferred stock:
	Series A		3,450,000		3,450,000		$	1,053		$	1,725
	Series B		2,547,252		2,547,252			4,413			4,500
	Series C		1,943,651		1,833,633			5,882			6,000
	Series D		3,934,855		3,934,855			25,354			27,027
	Series E		8,930,966		8,930,966			71,250			15,789
	Series F		3,064,087		2,951,128			22,468			22,468
	Series G		3,333,333		3,172,436			28,346			37,118
	Total		27,204,144		26,820,270		$	158,766		$	114,627
	Conversion of the Redeemable Convertible Preferred Stock
	In connection with the March 14, 2014 1-for-1.5 reverse stock split, the conversion prices for each series of redeemable convertible preferred stock were subject to a 1-for-1.5 adjustment. As a result, upon the closing of the IPO, the 23,647,834 outstanding shares of Series A, Series B, Series C, Series D, Series E and Series F redeemable convertible preferred stock converted into a total of 15,765,223 shares of common stock. Based on this 1-for-1.5 adjustment, the conversion price for the IPO adjustment specific to the Series G shares increased from $11.88 per share to $17.82 per share. Based on the public offering price of $14.00 per share, the 3,172,436 outstanding shares of Series G convertible preferred stock converted into a total of 2,692,012 shares of common stock, including an additional 577,055 shares of common stock issued as a result of the specific Series G IPO adjustment feature or “ratchet provision.” The ratchet provision, which is treated as a deemed stock dividend for accounting purposes, was calculated as the difference between the number of shares of common stock each holder of Series G would receive upon the automatic conversion of the Series G shares and the number of shares contingently issuable just prior to the automatic conversion based on the initial conversion price multiplied by the IPO price of $14.00 per share, which represents the fair value of the common stock on the date of conversion. In April 2014, the Company recorded a one-time $8,079 non-cash preferred stock deemed dividend related to the issuance of additional common shares resulting from the ratchet provision. Such non-cash preferred stock deemed dividend results in a decrease to net income to arrive at net income attributable to common stockholders and, consequently, results in an adjustment to the Company’s computation of net income per share attributable to common stockholders.
	Issuance of Common Stock Warrant
	In March 2014, the Company issued to one of its website partners a warrant to purchase 100,000 shares of common stock at $0.015 per share, in connection with the website partner agreeing to extend the advertising representation agreement by two years. The warrant was immediately exercisable and, accordingly, the Company calculated the fair value of the warrant using the Black-Scholes option pricing model and recorded $1,131 of deferred costs related to the issuance during the year ended December 31, 2014, which will be amortized to the Company’s operating results over the remaining life of the agreement.
	Authorized Capital
	As of December 31, 2014, the Company was authorized to issue 90,000,000 shares of its common stock and 10,000,000 shares of its preferred stock. As of December 31, 2014, the Company has reserved for issuance no shares under its 2003 Stock Option Plan, 347,371 shares under its 2014 Equity Incentive Plan and 361,816 shares for future issuance under the ESPP.

StockBased_Compensation

Stock-Based Compensation	12 Months Ended
	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	11. Stock-Based Compensation
	Stock Options
	The Company has historically granted non-statutory stock options to employees, directors and consultants of the Company pursuant to its 2003 Stock Option Plan, as amended (the “2003 Plan”). The Board of Directors and the Company’s stockholders subsequently approved the 2014 Equity Incentive Plan (the “2014 Plan”), which became effective immediately upon the signing of the underwriting agreement related to the IPO on March 27, 2014. Upon the effectiveness of the 2014 Plan, no additional options have been or will be granted under the 2003 Plan. Under the 2014 Plan, options are granted at prices not less than the estimated fair market value of the Company’s common stock on the date of grant. The options generally vest and become exercisable over four years from the date of grant and expire after ten years. Additionally, the Company granted 112,500 performance-based awards in 2014 where such options would vest and become exercisable over approximately nine months from the date of grant, dependent upon the Company meeting certain performance criteria. The performance criteria for these options were met at less than target, which resulted in the vesting of 90,555 of such 112,500 shares on December 31, 2014. The remaining 21,945 shares were cancelled on December 31, 2014.
	The aggregate number of shares of the Company’s common stock that may be issued pursuant to the 2014 Plan is the sum of (1) 200,000 shares, (2) the 388,781 shares reserved for issuance under the 2003 Plan at the time the 2014 Plan became effective, and (3) any shares subject to outstanding stock options that would otherwise have returned to the 2003 Plan (such as upon the expiration or termination of stock options prior to vesting). In addition, the number of shares of common stock reserved for issuance under the 2014 Plan will automatically increase on January 1 of each year from January 1, 2015 through January 1, 2024 by the lesser of (a) 4% of the total number of shares of the Company’s common stock outstanding on December 31 of the preceding calendar year and (b) a number of shares determined by the Board of Directors. As of December 31, 2014, 347,371 shares have been reserved for future issuance under the 2014 Plan.
	The following table summarizes stock option activity for the years ended December 31, 2014, 2013 and 2012:
		Number of			Weighted-				Weighted-			Aggregate
		options			average				average			intrinsic value
					exercise price				remaining
									contractual
									life (years)
	Outstanding at December 31, 2011		4,163,677			$	7.43			7.25			$	3,194
	Granted		1,453,961				6.78
	Exercised		(46,505	)			3.62
	Cancelled		(299,426	)			8.36
	Outstanding at December 31, 2012		5,271,707				7.28			7.01				10,556
	Granted		901,476				9.41
	Exercised		(183,501	)			4.31
	Cancelled		(531,891	)			7.67
	Outstanding at December 31, 2013		5,457,791				7.61			6.54				20,396
	Granted		1,945,851				14.67
	Exercised		(1,139,891	)			6.41
	Cancelled		(370,053	)			10.52
	Outstanding at December 31, 2014		5,893,698				9.94			6.48				29,249
	Exercisable at December 31, 2014		3,556,287				7.84			4.9				24,731
	The total intrinsic value of the options exercised during the years ended December 31, 2014, 2013 and 2012 was $8,080, $1,146 and $218, respectively.
	Proceeds from the exercise of options were $7,939, $101 and $168 for the years ended December 31, 2014, 2013 and 2012, respectively.
	The weighted-average fair value per share at date of grant for options granted during the years ended December 31, 2014, 2013 and 2012 was $7.53, $4.80 and $3.32, respectively. The fair value of options granted is estimated on the date of grant using the Black-Scholes option pricing model and recognized in expense over the vesting period of the options using the graded attribution method.
	The following table presents the weighted-average assumptions used to estimate the fair value of options granted in the years ended December 31, 2014, 2013 and 2012:
		2014			2013				2012
	Volatility		49.28	%			50.32	%		49.5	%
	Expected life (years)		6.25				6.25			6.25
	Risk-free interest rate		1.92	%			1.54	%		1.23	%
	Dividend yield		—				—			—
	The expected stock price volatilities are estimated based on historical realized volatilities of comparable publicly traded company stock prices over a period of time commensurate with the expected term of the option award. The expected life represents the period of time for which the options granted are expected to be outstanding. The Company used the simplified method for determining expected life for options qualifying for treatment due to the limited history the Company currently has with option exercise activity. The risk-free interest rate is based on the U.S. Treasury yield curve for periods equal to the expected term of the options on the grant date.
	Total stock-based compensation expense related to stock options was $7,920, $3,039 and $3,610 (including $0, $70 and $78 from discontinued operations) for the years ended December 31, 2014, 2013 and 2012, respectively.
	At December 31, 2014, there was approximately $6,902 of unrecognized compensation expense related to unvested stock options, which is expected to be recognized over a weighted-average period of 1.29 years. The total fair value of stock options vested during the years ended December 31, 2014, 2013 and 2012 was $4,328, $3,668 and $3,014, respectively.
	2014 Employee Stock Purchase Plan
	The Company’s directors adopted, and the stockholders subsequently approved, the ESPP. The ESPP, which became effective immediately upon the signing of the underwriting agreement related to the IPO on March 27, 2014, authorizes the issuance of 500,000 shares of the Company’s common stock pursuant to purchase rights granted to employees. The number of shares of common stock reserved for issuance under the ESPP will automatically increase on January 1 of each calendar year from January 1, 2015 through January 1, 2024 by the least of (a) 1% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, (b) 400,000 shares and (c) a number determined by the Board of Directors that is less than (a) and (b). Unless otherwise determined by the Board of Directors, common stock will be purchased for participating employees at a price per share equal to the lower of (a) 85% of the fair market value of a share of the common stock on the first date of an offering, or (b) 85% of the fair market value of a share of the common stock on the date of purchase. Generally, all regular employees may participate in the ESPP and may contribute, through payroll deductions, up to 15% of their earnings toward the purchase of common stock under the ESPP. Under the terms of the ESPP, there are defined limitations as to the amount and value of common stock that can be purchased by each employee.
	For the year ended December 31, 2014, employees purchased 138,184 shares for $1,592 under the ESPP, and charges incurred under the ESPP totaled $1,180. As of December 31, 2014, 361,816 shares of common stock were reserved for future issuance under the ESPP.

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	12. Income Taxes
	The provision (benefit) from continuing operations for income taxes consists of the following:
		2014				2013				2012
	Federal		$	250			$	—			$	—
	State			110				95				62
	Foreign			45				45				33
	Total current			405				140				95
	Federal			(7,058	)			749				749
	State			(2,013	)			213				182
	Total deferred			(9,071	)			962				931
	Total		$	(8,666	)		$	1,102			$	1,026
	The current income tax provision for the years ended December 31, 2014, 2013 and 2012 consisted of federal and state income taxes and foreign taxes. For the year ended December 31, 2014, the deferred income tax benefit includes a one-time tax benefit of $10,033 associated with the remeasurement of the valuation allowances against the Company’s deferred tax assets related to the DD acquisition (see Note 3), partially offset by a deferred tax charge relating to the basis differences in indefinite-lived intangible assets that cannot be offset by current year deferred tax assets. For the years ended December 31, 2013 and 2012, the deferred income tax charge relates to basis differences in indefinite-lived intangible assets that cannot be offset by current and prior year deferred tax assets.
	The significant components of the Company’s deferred tax assets (liabilities) were as follows:
		December 31,
		2014				2013
	Deferred tax assets:
	Net operating loss carryforwards		$	40,899			$	44,856
	Allowance for doubtful accounts			258				148
	Intangible and other assets			1,595				1,569
	Deferred revenue			190				304
	Stock-based compensation			9,504				7,886
	Accrued expenses and other			4,038				4,348
	AMT credit			250				—
	Depreciation			1,722				530
	Total deferred tax assets			58,456				59,641
	Valuation allowance			(46,577	)			(57,169	)
	Net deferred tax assets			11,879				2,472
	Deferred tax liabilities:
	Depreciation			(69	)			—
	Goodwill			(6,028	)			(5,066	)
	Intangible and other assets			(11,799	)			(2,472	)
	Total deferred tax liabilities			(17,896	)			(7,538	)
	Net deferred tax liabilities		$	(6,017	)		$	(5,066	)
	The Company has provided a valuation allowance against deferred tax assets to the extent the Company has determined that it is more likely than not that such net deferred tax assets will not be realized. In determining realizability, the Company considered numerous factors including historical profitability and reversing temporary differences, exclusive of indefinite-lived intangibles. The Company’s net deferred tax liabilities increased by $951 in 2014 due primarily to basis differences in indefinite- lived intangible assets that cannot be offset by current year deferred tax assets.
	At December 31, 2014, the Company had approximately $107,000 of U.S. federal and state net operating loss (“NOL”) carryforwards available to offset future taxable income. The U.S. federal NOL carryforwards will expire from 2020 through 2033. The full utilization of these losses in the future is dependent upon the Company’s ability to generate taxable income and may also be limited due to ownership changes, as defined under the provisions of Section 382 of the Internal Revenue Code, as amended. The Company’s NOL carryforwards at December 31, 2014 include $7,433 of income tax deductions related to equity compensation that are greater than the compensation recognized for financial reporting, which will be reflected as a credit to additional paid-in-capital as realized.
	The difference between the tax provision computed at the statutory rate and the tax provision recorded by the Company primarily relates to the release of the valuation allowance resulting from the DD acquisition. A reconciliation between the statutory rate and the effective tax rate for the years ended December 31, 2014, 2013 and 2012 is as follows:
		Year Ended December 31,
		2014				2013				2012
	Provision (benefit) at statutory rate		$	1,406			$	(4,163	)		$	(6,360	)
	Permanent items			885				311				236
	State taxes			(1,228	)			210				159
	Changes in valuation allowance			(9,729	)			4,744				6,991
	Total (benefit) provision		$	(8,666	)		$	1,102			$	1,026
	As of December 31, 2014, 2013 and 2012, there were no unrecognized tax benefits.
	The Company is subject to taxation in the U.S. and various state, local and foreign jurisdictions. In March 2014, an audit of the Company’s U.S. Federal tax return for the year ended December 31, 2011 commenced. As of December 31, 2014, none of the Company’s other tax returns have been examined by any income taxing authority. The Company files income tax returns in the U.S. and various state and foreign jurisdictions. The Company is not subject to U.S. federal, state or non-U.S. income tax examinations by tax authorities for the years prior to 2010. However, to the extent U.S. federal and state NOL carryforwards are utilized, the use of NOLs could be subject to examination by the tax authorities. The Company believes that it has appropriate support for the income tax positions taken and to be taken on its tax returns and that its accruals for tax liabilities are adequate for all open years based on assessment of many factors, including past experience and interpretations of tax law. The Company regularly assesses the adequacy of its income tax contingencies in accordance with ASC 740. As a result, the Company may adjust its income tax contingency liabilities for the impact of new facts and developments, such as changes in interpretations of relevant tax law and assessments from taxing authorities.

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	13. Commitments and Contingencies
	Operating Leases
	The Company is a party to certain non-cancellable operating leases for office space. The future minimum lease commitments for these leases, which expire on various dates through 2023, net of related aggregate sublease rentals, are as follows as of December 31, 2014:
	2015	$	4,042
	2016		3,782
	2017		3,532
	2018		3,328
	2019		3,419
	Thereafter		14,915
	Sublease rentals		(2,068	)
	Net lease commitments	$	30,950
	Rent expense was approximately $3,625, $3,377 and $3,009, net of sublease income of $427, $102 and $78, for the years ended December 31, 2014, 2013 and 2012, respectively.
	Minimum Guaranteed Payments
	The Company has entered into certain agreements with website partners, pursuant to which the Company is required to pay minimum guaranteed payments over the term of the agreement, regardless of revenue generated by the Company. Future minimum guaranteed payments as of December 31, 2014, are as follows:
	2015	$	19,095
	2016		13,934
	2017		12,257
	2018		12,135
	2019		12,322
	Thereafter		22,889
	Total	$	92,632
	Certain minimum guaranteed payments with respect to these agreements are subject to reductions if specified performance metrics are not maintained by the other party.
	Contingency
	The Company is subject to certain claims that have arisen in the ordinary conduct of business. Based on the advice of counsel and an assessment of the nature and status of any potential claim, and taking into account any accruals the Company may have established for them, the Company currently believes that any liabilities ultimately resulting from such claims will not, individually or in the aggregate, have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows.

Benefit_Plan

Benefit Plan	12 Months Ended
	Dec. 31, 2014
Compensation and Retirement Disclosure [Abstract]
Pension and Other Postretirement Benefits Disclosure [Text Block]	14. Benefit Plan
	The Company sponsors a defined contribution 401(k) plan covering all eligible employees, which is subject to the provisions of the Employee Retirement Income Security Act of 1974. Participants of the plan may make annual contributions up to the applicable IRS limit. The Company initiated a matching contribution to the plan commencing in 2011, for which the Company expensed $487, $409 and $339 during the years ended December 31, 2014, 2013 and 2012, respectively.

RelatedParty_Transactions

Related-Party Transactions	12 Months Ended
	Dec. 31, 2014
Related Party Transactions [Abstract]
Related Party Transactions Disclosure [Text Block]	15. Related-Party Transactions
	During the years ended December 31, 2013 and 2012, a consulting firm wholly-owned by one of the Company’s directors provided sales consulting services to the Company totaling $142 and $554, respectively. During the year ended December 31, 2012, the Company engaged a financial advisory firm to assist with certain financing initiatives for fees totaling $630. One of the Company’s directors was the executive chairman of the financial advisory firm until December 31, 2012.

Supplemental_Disclosure_of_Cas

Supplemental Disclosure of Cash Flow Information	12 Months Ended
	Dec. 31, 2014
Supplemental Cash Flow Elements [Abstract]
Cash Flow, Supplemental Disclosures [Text Block]	16. Supplemental Disclosure of Cash Flow Information
	Supplemental information related to the consolidated statements of cash flows is summarized below:
		Year Ended December 31,
		2014			2013			2012
	Supplemental disclosure of cash flow information:
	Interest paid		$	3,734		$	6,173		$	3,464
	Income taxes paid			341			73			55
	Supplemental disclosure of non-cash investing and financing activities:
	Issuance of common stock for acquired business		$	919		$	2,921		$	700
	Warrants issued in connection with credit facilities		$	—		$	149		$	3,452
	Warrants issued in connection with website partner agreement		$	1,131		$	—		$	—
	Capital lease obligations incurred		$	466		$	879		$	869
	Amounts due from stock option exercises		$	43		$	688		$	—

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2014
Subsequent Events [Abstract]
Subsequent Events [Text Block]	17. Subsequent Events
	The Company has completed an evaluation of all subsequent events through the issuance date of these financial statements and concluded that no subsequent events occurred that required recognition to the financial statements or disclosures in the notes to the consolidated financial statements.

Quarterly_Financial_Data_Unaud

Quarterly Financial Data (Unaudited)	12 Months Ended
	Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]
Quarterly Financial Information [Text Block]	18. Quarterly Financial Data (unaudited)
	The following tables summarize the quarterly financial data for the years ended December 31, 2014 and 2013:
		2014
		First				Second				Third				Fourth
		quarter				quarter				quarter				quarter
	Revenues
	Advertising and sponsorship revenues		$	32,692			$	36,882			$	37,910			$	58,981
	Premium services revenues			4,813				4,565				4,414				4,068
	Total revenues			37,505				41,447				42,324				63,049
	Operating expenses:
	Cost of revenues			11,421				10,961				11,006				15,908
	Sales and marketing			10,220				12,216				12,213				13,956
	Product development			10,762				10,805				10,886				12,088
	General and administrative			6,595				7,126				7,504				8,816
	Total operating expenses			38,998				41,108				41,609				50,768
	Income (loss) from operations			(1,493	)			339				715				12,281
	Interest expense, net			(1,863	)			(585	)			(500	)			(763	)
	Other expense			(4,114	)			—				—				—
	Income (loss) from continuing operations before provision for income taxes			(7,470	)			(246	)			215				11,518
	Provision for income taxes			—				—				—				—
	(Loss) income from continuing operations			—				—				—				—
	Loss from discontinued operations, net of tax			—				—				—				—
	Benefit (provision) for income taxes			(289	)			(349	)			(365	)			9,669
	Net income (loss)			(7,759	)			(595	)			(150	)			21,187
	Series G preferred stock deemed dividend			—				(8,079	)			—				—
	Net income (loss) attributable to common stockholders		$	(7,759	)		$	(8,674	)		$	(150	)		$	21,187
	Basic net income (loss) attributable to common stockholders per common share:
	Net income (loss) attributable to common stockholders from continuing operations			—				—				—				—
	Net loss attributable to common stockholders from discontinued operations, net of tax			—				—				—				—
	Net income (loss) attributable to common stockholders			—				—				—				—
	Diluted net income (loss) attributable to common stockholders per common share:
	Net income (loss) attributable to common stockholders from continuing operations			—				—				—				—
	Net loss attributable to common stockholders from discontinued operations, net of tax			—				—				—				—
	Net income (loss) attributable to common stockholders			—				—				—				—
	Net income (loss) attributable to common stockholders per common share:
	Basic		$	(1.44	)		$	(0.29	)		$	(0.00	)		$	0.68
	Diluted		$	(1.44	)		$	(0.29	)		$	(0.00	)		$	0.64
	Weighted-average common shares outstanding:
	Basic			5,403,846				29,802,970				30,404,529				31,076,588
	Diluted			5,403,846				29,802,970				30,404,529				32,977,544
		2013
		First				Second				Third				Fourth
		quarter				quarter				quarter				quarter
	Revenues
	Advertising and sponsorship revenues		$	25,380			$	31,819			$	29,662			$	48,032
	Premium services revenues			5,124				5,379				5,392				5,062
	Total revenues			30,504				37,198				35,054				53,094
	Operating expenses:
	Cost of revenues			9,835				10,826				9,620				13,057
	Sales and marketing			9,061				11,860				10,814				12,650
	Product development			10,160				10,700				10,656				12,243
	General and administrative			6,539				6,191				6,462				8,270
	Total operating expenses			35,595				39,577				37,552				46,220
	(Loss) income from operations			(5,091	)			(2,379	)			(2,498	)			6,874
	Interest expense, net			(2,129	)			(2,015	)			(2,125	)			(2,173	)
	Other expense			—				—				—				(359	)
	(Loss) income from continuing operations before provision for income taxes			(7,220	)			(4,394	)			(4,623	)			4,342
	Provision for income taxes			(264	)			(247	)			(311	)			(280	)
	(Loss) income from continuing operations			(7,484	)			(4,641	)			(4,934	)			4,062
	Loss from discontinued operations, net of tax			(1,745	)			(1,596	)			(397	)			(1,501	)
	Benefit (provision) for income taxes			—				—				—				—
	Net income (loss)		$	(9,229	)		$	(6,237	)		$	(5,331	)		$	2,561
	Series G preferred stock deemed dividend			—				—				—				—
	Net income (loss) attributable to common stockholders			—				—				—				—
Basic net income (loss) attributable to common stockholders per common share:
Net income (loss) attributable to common stockholders from continuing operations		$	(1.52	)		$	(0.92	)		$	(0.95	)		$	0.78
Net loss attributable to common stockholders from discontinued operations, net of tax			(0.35	)			(0.32	)			(0.08	)			(0.29	)
Net income (loss) attributable to common stockholders		$	(1.87	)		$	(1.24	)		$	(1.02	)		$	0.49
Diluted net income (loss) attributable to common stockholders per common share:
Net income (loss) attributable to common stockholders from continuing operations		$	(1.52	)		$	(0.92	)		$	(0.95	)		$	0.16
Net loss attributable to common stockholders from discontinued operations, net of tax			(0.35	)			(0.32	)			(0.08	)			(0.29	)
Net income (loss) attributable to common stockholders		$	(1.87	)		$	(1.24	)		$	(1.02	)		$	0.1
Net income (loss) attributable to common stockholders per common share—basic and diluted
Basic			—				—				—				—
Diluted			—				—				—				—
Weighted-average common shares outstanding:
Basic			4,925,306				5,030,265				5,213,706				5,239,463
Diluted			4,925,306				5,030,265				5,213,706				25,398,572

Accounting_Policies_by_Policy_

Accounting Policies, by Policy (Policies)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of Consolidation
	The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries. The results of operations for companies acquired are included in the consolidated financial statements from the effective date of the acquisition. All significant intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates
	The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates on historical experience, current business factors and other available information. Actual results could differ from those estimates. On an ongoing basis, the Company evaluates its estimates and assumptions, including those related to revenue recognition and deferred revenue, allowance for doubtful accounts, internal software development costs and website development costs, valuation of long-lived assets, goodwill and other intangible assets, income taxes and stock-based compensation.
Reclassification, Policy [Policy Text Block]	Reclassifications
	Certain reclassifications have been made to the prior year financial statements to conform to the December 31, 2014 presentation.
Sale of Stock, Description of Transaction	Initial Public OfferingOn April 2, 2014, the Company closed its initial public offering of common stock (“IPO”). The IPO, including the additional shares issued and sold on April 30, 2014 pursuant to the underwriters’ exercise of their over-allotment option, resulted in net proceeds of $70,622, after deducting underwriting discounts and commissions and offering costs borne by the Company totaling $8,848. As a result of the IPO, the Company’s common stock, redeemable convertible preferred stock, additional paid-in capital, and stock options and warrants to purchase stock changed as follows (collectively, the “IPO- Related Transactions”): (i) the Company issued and sold 5,676,414 shares of common stock at a public offering price of $14.00 per share, (ii) all of the Company’s redeemable convertible preferred stock outstanding automatically converted into an aggregate of 18,457,235 shares of common stock, including 577,055 additional shares of common stock related to the Series G redeemable convertible preferred stock ratchet provision (refer to Note 10), (iii) certain selling stockholders exercised stock options and warrants for an aggregate of 339,053 shares of common stock, (iv) 149,839 shares of common stock were issued upon the automatic net exercise of a warrant, and (v) outstanding warrants to purchase 222,977 shares of redeemable convertible preferred stock automatically converted into warrants to purchase an aggregate of 148,650 shares of common stock, which resulted in the reclassification of the preferred stock warrant liability of $1,140 to additional paid-in capital.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents
	The Company considers all highly liquid investments with original maturities of three months or less when purchased to be cash equivalents. Cash equivalents principally consist of the Company’s investment in U.S. Treasury securities and other money market funds. The fair value of these investment funds is based on quoted market prices, which are Level 1 inputs, pursuant to the fair value accounting standard, which establishes a framework for measuring fair value and requires disclosures about fair value measurements by establishing a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value.
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment
	Property and equipment are stated at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the assets, ranging from three to five years. Amortization of leasehold improvements is computed using the straight-line method over the shorter of the lease term or the estimated useful life of the improvement.
Video and Television Costs Policy	Video and Television Costs
	The Company entered into agreements during 2011 and 2012 for the creation and production of a health/wellness television series, a recipe/food television series and a YouTube health channel. Video and television costs related to these productions are stated at the lower of cost, less accumulated amortization, or fair value in the consolidated balance sheets. The amount of capitalized video and television costs recognized in operating expense for a given period is determined using the film forecast computation method. Under this method, the amortization of capitalized costs is based on the proportion of the production’s revenues recognized for such period to the production’s estimated remaining ultimate revenues. All video and television costs relating to these productions were fully amortized as of December 31, 2013. Amortization expense of video and television costs, aggregating $632 and $6,430 for the years ended December 31, 2013 and 2012, respectively, is included in product development expense in the consolidated statements of operations.
Capitalization of Internal Costs, Policy [Policy Text Block]	Internal Software Development Costs
	The Company incurs costs to develop software for internal use. The Company expenses all costs that relate to the planning and post-implementation phases of development as product development expense. Costs incurred in the application development phase, consisting principally of payroll and related benefits, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years.
Website Development Costs Policy	Website Development Costs
	The Company incurs costs to develop its website applications. The Company expenses all costs that relate to the planning and post-implementation phases of website development as product development expense. Costs incurred in the application development phase, consisting principally of third-party consultants and related charges, and the costs of content determined to provide a future economic benefit, are capitalized. Upon completion, the capitalized costs are amortized using the straight-line method over their estimated useful lives, which is generally three years.
Goodwill and Intangible Assets, Policy [Policy Text Block]	Goodwill
	Goodwill represents the excess cost over fair value of the identifiable net assets of acquired businesses.
	Goodwill is tested for impairment on an annual basis as of October 1, and whenever events or circumstances indicate that the carrying value of the asset may not be recoverable.
	An initial qualitative analysis is performed evaluating whether any events and circumstances occurred or exist that provide evidence that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, based on this analysis, indicators deem it more likely than not that the fair value of the reporting unit is less than its carrying amount, then the two-step quantitative impairment test is performed; otherwise, no further step is required.
	If and when needed to complete the two-step quantitative assessment, the fair value of goodwill is estimated using a combination of an income approach based on the present value of estimated future cash flows, and a market approach examining transactions in the marketplace involving the sale of stocks of similar publicly traded companies, or the sale of entire companies engaged in operations similar to those of the Company. As the Company has one operating segment and one reporting unit, the first step of the impairment test requires a comparison of the fair value of the reporting unit, or business enterprise value as a whole, to the carrying value of the Company’s invested capital. If the carrying amount exceeds the fair value, there is indication that an impairment may exist, and a second step must be performed. If the carrying amount is less than the fair value, no indication of impairment exists, and a second step is not performed.
	The evaluation of the Company’s goodwill indicated that the carrying value of the asset was less than the fair value and, accordingly, there was no impairment loss recognized for the years ended December 31, 2014, 2013 and 2012.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Long-Lived Assets
	The Company reviews long-lived assets, including property and equipment and intangible assets with definite lives, for impairment whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. The intangible assets with definite lives consist principally of trade names, customer relationships and agreements with certain of the Company’s website partners. Definite-lived intangible assets are amortized over their estimated useful lives, ranging from three to ten years, using the straight-line method which approximates the pattern in which economic benefits are consumed. In accordance with its policy, the Company reviews the estimated useful lives of its intangible assets on an ongoing basis. There were no indicators of impairment of the Company’s long-lived assets during the year ended December 31, 2014. During the year ended December 31, 2013, the Company recorded impairment charges of $1,190 related to the consolidation and reorganization of certain website content and tools. This $1,190 charge is included in product development expense in the accompanying consolidated statements of operations. There were no indicators of impairment of the Company’s long-lived assets during the year ended December 31, 2012.
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition and Deferred Revenue
	The Company generates its revenue from advertising and sponsorships, premium services, including subscriptions and licensing fees, and, to a lesser extent, video production fees. Advertising revenue is recognized in the period in which the advertisement is delivered. Revenue from sponsorships is recognized over the period the Company substantially satisfies its contractual obligations as required under the respective sponsorship agreements. When contractual arrangements contain multiple elements, revenue is allocated to each element based on its relative fair value determined using prices charged when elements are sold separately. In instances where individual deliverables are not sold separately, or when third-party evidence is not available, fair value is determined based on management’s best estimate of selling price.
	Subscriptions are generally paid in advance on a monthly, quarterly or annual basis. Subscription revenue, after deducting refunds and charge-backs, is recognized on a straight-line basis ratably over the subscription periods. Licensing revenue is generally recognized over the life of the contract. Video production fee revenue is recognized as the video content is completed and delivered to the customer.
	Deferred revenue relates to: (i) subscription fees for which amounts have been collected but for which revenue has not been recognized, and (ii) advertising and sponsorship fees and licensing fees billed in advance of when the revenue is to be earned.
Cost of Sales, Policy [Policy Text Block]	Cost of Revenues
	Cost of revenues consists principally of the expenses associated with aggregating the total audience across the Company’s portfolio of websites, including (i) royalty expenses for licensing content for certain websites within the portfolio and for the portion of advertising revenue the Company pays to the owners of certain other websites within the portfolio, and (ii) media costs associated with audience aggregation activities. Cost of revenues also includes credit card fees and service charges associated with subscription fees for the Company’s premium services.
	Royalty expense amounted to $20,937, $18,673 and $12,898 for the years ended December 31, 2014, 2013 and 2012, respectively.
	Media costs consist primarily of fees paid to online publishers, Internet search companies and other media channels for search engine and database marketing, and display and television advertising. These media activities are attributable to revenue-generating and audience aggregation events, designed to increase the audience to the websites the Company operates, increase the number of subscribers to premium services and grow the Company’s registered user base. Media costs totaled $24,973, $22,437 and $23,841 for the years ended December 31, 2014, 2013 and 2012, respectively.
Other Income and Other Expense Disclosure [Text Block]	Other Expense
	In connection with the refinancing of its credit facilities in 2014, the Company wrote-off unamortized deferred financing costs totaling $2,845 and incurred prepayment fees of $1,016, which, together with the mark-to-market adjustment on certain preferred stock warrants of $253, is reflected as other expense in the accompanying consolidated statements of operations for the year ended December 31, 2014. In connection with the refinancing of its credit facilities in 2012, the Company wrote-off unamortized deferred financing costs totaling $1,069, which is reflected as other expense in the accompanying consolidated statements of operations for the year ended December 31, 2012.
Income Tax, Policy [Policy Text Block]	Income Taxes
	The Company accounts for taxes under the asset and liability method. Under this method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the tax and financial statement reporting basis of assets and liabilities.
	Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company reduces the measurement of a deferred tax asset, if necessary, by a valuation allowance if it is more likely than not that the Company will not realize some or all of the deferred tax asset. As a result of the Company’s historical operating performance and the cumulative net losses incurred to date, the Company does not have sufficient objective evidence to support the recovery of the net deferred tax assets. Accordingly, the Company has established a valuation allowance against net deferred tax assets for financial reporting purposes to the extent it is determined that such deferred tax assets are not more likely than not to be realized.
	The Company accounts for uncertain tax positions by recognizing the financial statement effects of a tax position only when, based upon technical merits, it is “more likely than not” that the position will be sustained upon examination. Potential interest and penalties associated with unrecognized tax positions are recognized in income tax expense.
Comprehensive Income, Policy [Policy Text Block]	Comprehensive Income (Loss)
	Other than the Series G preferred stock deemed dividend reflected in the accompanying statement of operations for the year end December 31, 2014 (see Note 10), the Company has no items of other comprehensive income (loss).
Fair Value of Financial Instruments, Policy [Policy Text Block]	Fair Value of Financial Instruments
	Due to their short-term maturities, the carrying amounts of the Company’s financial instruments, including cash and cash equivalents, accounts receivable, accounts payable and accrued expenses, approximate fair value. Cash equivalents principally consist of the Company’s investment in U.S. Treasury securities and other highly liquid money market funds. The fair value of these investment funds is based on quoted market prices, which are Level 1 inputs, pursuant to the fair value accounting standard, which establishes a framework for measuring fair value and requires disclosures about fair value measurements by establishing a hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The fair value of the Company’s debt approximates the recorded amounts as the interest rates on the credit facilities are based on market interest rates.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation
	The Company accounts for all share-based payments, including grants of employee stock options, based on the fair value of the award measured at the grant date. The Company uses the Black-Scholes option pricing model to estimate the fair value of the stock option awards. Stock-based compensation expense is recognized over the period during which the recipient provides services, generally the vesting period.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Business Concentrations, Accounts Receivable and Credit Risk
	Financial instruments which potentially subject the Company to concentration of credit risk consist principally of cash and cash equivalents and accounts receivable.
	Cash and cash equivalents includes U.S. Treasury securities and other money market funds.
	Concentration of credit risk with respect to accounts receivable is limited due to the large number of customers comprising the Company’s customer base and the ongoing credit evaluation of its customers.
	For the year ended December 31, 2014, no advertising customer accounted for greater than 10% of total revenues. For the year ended December 31, 2013, one advertising customer accounted for 12% of total revenues. For the year ended December 31, 2012, no advertising customer accounted for greater than 10% of total revenues. As of December 31, 2014, no advertising customers accounted for greater than 10% of total accounts receivable. As of December 31, 2013, one advertising customer accounted for 16% of accounts receivable. As many of the Company’s advertising customers work through the same advertising agencies, the Company also monitors the concentration of accounts receivable at the agency level. As of December 31, 2014, no advertising agency accounted for greater than 10% of accounts receivable. As of December 31, 2013, three advertising agencies accounted for 14%, 11% and 11% of accounts receivable, respectively.
	The Company’s accounts receivable balance of $68,007 and $49,373 reflected in the accompanying balance sheets as of December 31, 2014 and 2013, respectively, include unbilled accounts receivable of $7,064 as of December 31, 2014 and $290 as of December 31, 2013. The $7,064 consists of $4,482 of unbilled accounts receivable relating to DoctorDirectory.com, Inc. contracts (see Note 3) for which billings were not issued as of December 31, 2014, and $2,582 of revenue earned on the Company’s advertising and sponsorship contracts which were not contractually billable as of such date.
	An allowance for doubtful accounts is established with respect to accounts receivable that the Company has determined to be doubtful of collection, based upon factors surrounding the credit risk of customers, historical experience and other information.
	The following table summarizes the activity of the allowance for doubtful accounts:
			Year Ended December 31,
			2014				2013				2012
	Balance at beginning of year			$	530			$	651			$	835
	Bad debt provision				384				251				501
	Write-offs				(277	)			(372	)			(685	)
	Balance at end of year			$	637			$	530			$	651
Business Combinations Policy [Policy Text Block]	Business Combinations
	The Company allocates the fair value of purchase consideration to the tangible assets acquired, liabilities assumed and intangible assets acquired based on their estimated fair values. The excess of the fair value of purchase consideration over the fair values of these identifiable assets and liabilities is recorded as goodwill. Such valuations require management to make significant estimates and assumptions, especially with respect to intangible assets. During the measurement period, which is up to one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed, based on additional information impacting the assigned estimated fair values.
Segment Reporting, Policy [Policy Text Block]	Segment Information
	The Company and its subsidiaries are organized in a single operating segment, providing online health solutions, and the Company also has one reportable segment. Substantially all of the Company’s revenues are derived from U.S. sources
Earnings Per Share, Policy [Policy Text Block]	Net Income (Loss) Attributable to Common Stockholders per Common Share
	Basic net income (loss) attributable to common stockholders per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period.
	Diluted net income (loss) attributable to common stockholders per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted-average number of shares of common stock outstanding for the period, adjusted to reflect potentially dilutive securities. Potentially dilutive securities consist of incremental shares issuable upon the assumed exercise of stock options and warrants using the treasury stock method, convertible preferred shares using the “if-converted” method, and employee withholdings to purchase common stock under the Company’s 2014 Employee Stock Purchase Plan, or ESPP. For the years ended December 31, 2013 and 2012, the Company had outstanding options, warrants and convertible preferred stock which were not included in the computation of diluted net loss per common share because the effect would have been anti-dilutive.
	The basic and diluted net income (loss) attributable to common stockholders per common share is calculated as follows for the periods presented:
			Year Ended December 31,
			2014				2013				2012
	Numerator:
	Income (loss) from continuing operations			$	12,683			$	(12,997	)		$	(19,197	)
	Loss from discontinued operations, net of tax				—				(5,239	)			(3,257	)
	Net income (loss)				12,683				(18,236	)			(22,454	)
	Series G preferred stock deemed dividend				(8,079	)			—				—
	Net income (loss) attributable to common stockholders			$	4,604			$	(18,236	)		$	(22,454	)
	Denominator:
	Weighted-average number of common shares outstanding for basic net income (loss) attributable to common stockholders per common share				24,259,395				5,103,351				4,791,474
	Dilutive securities:
	Stock option awards (1)				2,235,059				—				—
	Warrants to purchase common stock				412,305				—				—
	Employee stock purchase plan				5,023				—				—
	Total weighted-average diluted shares				26,911,782				5,103,351				4,791,474
	Basic net income (loss) attributable to common stockholders per common share:
	Income (loss) from continuing operations			$	0.19			$	(2.55	)		$	(4.01	)
	Loss from discontinued operations, net of tax				—				(1.03	)			(0.68	)
	Net income (loss) attributable to common stockholders			$	0.19			$	(3.57	)		$	(4.69	)
	Diluted net income (loss) attributable to common stockholders per common share:
	Income (loss) from continuing operations			$	0.17			$	(2.55	)		$	(4.01	)
	Loss from discontinued operations, net of tax				—				(1.03	)			(0.68	)
	Net income (loss) attributable to common stockholders			$	0.17			$	(3.57	)		$	(4.69	)
		-1		The weighted-average diluted shares for the year ended December 31, 2014 excludes a weighted-average number of stock options of 1,337,766 which were anti-dilutive.
Foreign Currency Transactions and Translations Policy [Policy Text Block]	Foreign Currency
	The financial statements and transactions of the Company’s foreign subsidiary are maintained in its local currency. The translation of foreign currencies into United States dollars is performed for balance sheet accounts using current exchange rates in effect at the balance sheet date, and for revenue and expense accounts using average exchange rates during the year. Foreign currency gains or losses are included in the consolidated statements of operations and were not material in any of the periods presented.
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued and Adopted Accounting Standards
	In July 2013, the Financial Accounting Standards Board (“FASB”) issued amended guidance for income taxes. This amendment requires that entities present an unrecognized tax benefit, or portion of an unrecognized tax benefit, as a reduction to a deferred tax asset in the financial statements for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward, with certain exceptions. The Company adopted this amended guidance beginning in the quarter ended March 31, 2014. The adoption of this guidance had no impact on the Company’s consolidated financial statements.
	In April 2014, the FASB issued amended guidance for reporting discontinued operations. Under the new guidance, only disposals that represent a strategic shift having a material impact on an entity’s operations and financial results shall be reported as discontinued operations, with expanded disclosures. This amendment will be effective for the first annual reporting period beginning after December 15, 2015. The Company does not expect the impact of the adoption of this guidance to be material to the consolidated financial statements.
	In May 2014, the FASB issued amended guidance for revenue recognition. This amendment provides a comprehensive new revenue recognition model. The core principle of the guidance is to recognize revenue when promised goods or services are transferred to customers in an amount that reflects the consideration that is expected to be received for those goods or services. This amendment is effective for fiscal years beginning after December 15, 2016, and for interim periods within those fiscal years. Early adoption is not permitted. The standard permits the use of either the retrospective or cumulative effect transition method. The Company has not yet selected a transition method and is currently evaluating the effect that the new standard will have on the consolidated financial statements and related disclosures.
	In June 2014, the FASB issued updated guidance on stock compensation accounting requiring that a performance target that affects vesting and could be achieved after the requisite service period should be treated as a performance condition. Current GAAP does not contain explicit guidance on how to account for such share-based payments. This updated guidance is effective for fiscal years beginning after December 15, 2015, and for interim periods within those fiscal years. Early adoption is permitted. The Company does not expect the impact of the adoption of this guidance to be material to the consolidated financial statements.

Significant_Accounting_Policie1

Significant Accounting Policies (Tables)	12 Months Ended
	Dec. 31, 2014
Accounting Policies [Abstract]
Schedule Of Allowance For Doubtful Accounts [Table Text Block]	The following table summarizes the activity of the allowance for doubtful accounts:
		Year Ended December 31,
		2014				2013				2012
	Balance at beginning of year		$	530			$	651			$	835
	Bad debt provision			384				251				501
	Write-offs			(277	)			(372	)			(685	)
	Balance at end of year		$	637			$	530			$	651
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	The basic and diluted net income (loss) attributable to common stockholders per common share is calculated as follows for the periods presented:
		Year Ended December 31,
		2014				2013				2012
	Numerator:
	Income (loss) from continuing operations		$	12,683			$	(12,997	)		$	(19,197	)
	Loss from discontinued operations, net of tax			—				(5,239	)			(3,257	)
	Net income (loss)			12,683				(18,236	)			(22,454	)
	Series G preferred stock deemed dividend			(8,079	)			—				—
	Net income (loss) attributable to common stockholders		$	4,604			$	(18,236	)		$	(22,454	)
	Denominator:
	Weighted-average number of common shares outstanding for basic net income (loss) attributable to common stockholders per common share			24,259,395				5,103,351				4,791,474
	Dilutive securities:
	Stock option awards (1)			2,235,059				—				—
	Warrants to purchase common stock			412,305				—				—
	Employee stock purchase plan			5,023				—				—
	Total weighted-average diluted shares			26,911,782				5,103,351				4,791,474
	Basic net income (loss) attributable to common stockholders per common share:
	Income (loss) from continuing operations		$	0.19			$	(2.55	)		$	(4.01	)
	Loss from discontinued operations, net of tax			—				(1.03	)			(0.68	)
	Net income (loss) attributable to common stockholders		$	0.19			$	(3.57	)		$	(4.69	)
	Diluted net income (loss) attributable to common stockholders per common share:
	Income (loss) from continuing operations		$	0.17			$	(2.55	)		$	(4.01	)
	Loss from discontinued operations, net of tax			—				(1.03	)			(0.68	)
	Net income (loss) attributable to common stockholders		$	0.17			$	(3.57	)		$	(4.69	)

Acquisitions_Tables

Acquisitions (Tables)	12 Months Ended
	Dec. 31, 2014
Acquisitions (Tables) [Line Items]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]	The following table summarizes the tangible and intangible assets acquired, the liabilities assumed and the consideration paid:
	Cash		$	174
	Accounts receivable			1,167
	Other current assets			237
	Property and equipment			18
	Goodwill			9,904
	Intangible assets			1,130
	Other assets			26
	Accounts payable and accrued expenses			(1,819	)
	Deferred revenue			(625	)
	Other current liabilities			(555	)
	Total consideration paid		$	9,657
Business Acquisition, Pro Forma Information [Table Text Block]
		Unaudited
		Pro Forma Results
		Year Ended December 31,
		2014				2013
	Revenues		$	201,335			$	172,877
	Net income (loss)		$	4,640			$	(12,425	)
Estimate of Fair Value Measurement [Member]
Acquisitions (Tables) [Line Items]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]
	Accounts receivable		$	6,513
	Deferred tax asset			81
	Other current assets			232
	Property and equipment			1,612
	Goodwill			44,962
	Intangible assets			23,500
	Accounts payable and accrued expenses			(1,798	)
	Deferred tax liability			(10,102	)
	Total consideration paid		$	65,000

Discontinued_Operations_Tables

Discontinued Operations (Tables)	12 Months Ended
	Dec. 31, 2014
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block]	The loss from discontinued operations was comprised of the following:
		Year ended December 31,
		2013				2012
	Revenues		$	7,116			$	7,794
	Loss from operations		$	(3,971	)		$	(3,257	)
	Loss on sale			(1,268	)			—
	Loss from discontinued operations before tax			(5,239	)			(3,257	)
	Income tax (provision) benefit			—				—
	Net loss from discontinued operations		$	(5,239	)		$	(3,257	)

Prepaid_Expenses_and_Other_Cur1

Prepaid Expenses and Other Current Assets (Tables)	12 Months Ended
	Dec. 31, 2014
Prepaid Expenses And Other Current Assets [Abstract]
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block]	Prepaid expenses and other current assets consist of the following:
		December 31,
		2014			2013
	Prepaid royalties		$	1,225		$	1,195
	Initial public offering costs			—			1,083
	Prepaid marketing			422			714
	Amount due from buyer of business			—			400
	Restricted cash			—			500
	Other			3,882			3,930
	Total		$	5,529		$	7,822

Property_and_Equipment_Tables

Property and Equipment (Tables)	12 Months Ended
	Dec. 31, 2014
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment [Table Text Block]	Property and equipment consist of the following:
		December 31,
		2014				2013
	Computer equipment and purchased software		$	12,402			$	10,529
	Internally developed software			37,226				28,486
	Acquired technology			1,957				927
	Furniture, fixtures and office equipment			2,978				2,858
	Leasehold improvements			6,381				6,296
	Website development costs			25,292				20,425
				86,236				69,521
	Less accumulated depreciation and amortization			(60,734	)			(48,426	)
	Total		$	25,502			$	21,095
Depreciation And Amortization Expense Related To Property And Equipment [Table Text Block]	Depreciation and amortization expense related to property and equipment is classified as follows in the accompanying consolidated statements of operations:
		Year Ended December 31,
		2014				2013				2012
	Sales and marketing		$	1,286			$	1,183			$	1,065
	Product development			10,811				10,325				9,324
	General and administrative			327				350				423
	Total depreciation and amortization		$	12,424			$	11,858			$	10,812

Goodwill_and_Other_Intangible_1

Goodwill and Other Intangible Assets (Tables)	12 Months Ended
	Dec. 31, 2014
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets [Table Text Block]	Intangible assets consist of the following:
		31-Dec-14												31-Dec-13
		Gross			Accumulated				Net			Weighted-		Gross			Accumulated				Net			Weighted-
		carrying			amortization							average		carrying			amortization							average
		amount										remaining		amount										remaining
												useful												useful
												life(a)												life(a)
	Customer relationships		$	27,300		$	(11,247	)		$	16,053		9.5		$	11,910		$	(10,481	)		$	1,429		2.9
	Other intangibles			3,900			(3,482	)			418		0.7			3,900			(2,925	)			975		1.7
	Trade names			18,615			(4,370	)			14,245		6.5			10,505			(3,174	)			7,331		7
	Total		$	49,815		$	(19,099	)		$	30,716				$	26,315		$	(16,580	)		$	9,735
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Future amortization expense of the intangible assets is estimated to be as follows:
	2015		$	4,635
	2016			3,945
	2017			3,937
	2018			3,748
	2019			3,748
	Thereafter			10,703
	Total		$	30,716

Accounts_Payable_and_Accrued_E1

Accounts Payable and Accrued Expenses (Tables)	12 Months Ended
	Dec. 31, 2014
Payables and Accruals [Abstract]
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	Accounts payable and accrued expenses consist of the following:
		December 31,
		2014			2013
	Accounts payable		$	8,563		$	8,459
	Accrued compensation			8,260			8,282
	Accrued acquisition earn-outs			1,425			3,639
	Accrued royalties			5,991			6,589
	Accrued media and licensed content			3,716			3,178
	Accrued interest			408			943
	Accrued professional fees			718			872
	Other accrued expenses			2,641			2,416
	Total		$	31,722		$	34,378

LongTerm_Debt_Tables

Long-Term Debt (Tables)	12 Months Ended
	Dec. 31, 2014
Disclosure Text Block [Abstract]
Schedule of Maturities of Long-term Debt [Table Text Block]	Maturities of debt outstanding as of December 31, 2014 are as follows:
	2015	$	3,000
	2016		6,000
	2017		6,000
	2018		6,000
	2019		69,000
	Total	$	90,000

Common_Stock_and_Redeemable_Co1

Common Stock and Redeemable Convertible Preferred Stock (Tables)	12 Months Ended
	Dec. 31, 2014
Stockholders' Equity Note [Abstract]
Temporary Equity [Table Text Block]	The number of shares of the Company’s redeemable convertible preferred stock was not adjusted in connection with the 1-for-1.5 reverse stock split of common stock referred to above. The Company’s redeemable convertible preferred stock consisted of the following at December 31, 2013:
		Shares				Stated value,			Liquidation
		Authorized		Issued and		net of expenses			preference
				outstanding
	Redeemable convertible preferred stock:
	Series A		3,450,000		3,450,000		$	1,053		$	1,725
	Series B		2,547,252		2,547,252			4,413			4,500
	Series C		1,943,651		1,833,633			5,882			6,000
	Series D		3,934,855		3,934,855			25,354			27,027
	Series E		8,930,966		8,930,966			71,250			15,789
	Series F		3,064,087		2,951,128			22,468			22,468
	Series G		3,333,333		3,172,436			28,346			37,118
	Total		27,204,144		26,820,270		$	158,766		$	114,627

StockBased_Compensation_Tables

Stock-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	The following table summarizes stock option activity for the years ended December 31, 2014, 2013 and 2012:
		Number of			Weighted-				Weighted-			Aggregate
		options			average				average			intrinsic value
					exercise price				remaining
									contractual
									life (years)
	Outstanding at December 31, 2011		4,163,677			$	7.43			7.25			$	3,194
	Granted		1,453,961				6.78
	Exercised		(46,505	)			3.62
	Cancelled		(299,426	)			8.36
	Outstanding at December 31, 2012		5,271,707				7.28			7.01				10,556
	Granted		901,476				9.41
	Exercised		(183,501	)			4.31
	Cancelled		(531,891	)			7.67
	Outstanding at December 31, 2013		5,457,791				7.61			6.54				20,396
	Granted		1,945,851				14.67
	Exercised		(1,139,891	)			6.41
	Cancelled		(370,053	)			10.52
	Outstanding at December 31, 2014		5,893,698				9.94			6.48				29,249
	Exercisable at December 31, 2014		3,556,287				7.84			4.9				24,731
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	The following table presents the weighted-average assumptions used to estimate the fair value of options granted in the years ended December 31, 2014, 2013 and 2012:
		2014			2013				2012
	Volatility		49.28	%			50.32	%		49.5	%
	Expected life (years)		6.25				6.25			6.25
	Risk-free interest rate		1.92	%			1.54	%		1.23	%
	Dividend yield		—				—			—

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Tax Disclosure [Abstract]
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	The provision (benefit) from continuing operations for income taxes consists of the following:
		2014				2013				2012
	Federal		$	250			$	—			$	—
	State			110				95				62
	Foreign			45				45				33
	Total current			405				140				95
	Federal			(7,058	)			749				749
	State			(2,013	)			213				182
	Total deferred			(9,071	)			962				931
	Total		$	(8,666	)		$	1,102			$	1,026
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	The significant components of the Company’s deferred tax assets (liabilities) were as follows:
		December 31,
		2014				2013
	Deferred tax assets:
	Net operating loss carryforwards		$	40,899			$	44,856
	Allowance for doubtful accounts			258				148
	Intangible and other assets			1,595				1,569
	Deferred revenue			190				304
	Stock-based compensation			9,504				7,886
	Accrued expenses and other			4,038				4,348
	AMT credit			250				—
	Depreciation			1,722				530
	Total deferred tax assets			58,456				59,641
	Valuation allowance			(46,577	)			(57,169	)
	Net deferred tax assets			11,879				2,472
	Deferred tax liabilities:
	Depreciation			(69	)			—
	Goodwill			(6,028	)			(5,066	)
	Intangible and other assets			(11,799	)			(2,472	)
	Total deferred tax liabilities			(17,896	)			(7,538	)
	Net deferred tax liabilities		$	(6,017	)		$	(5,066	)
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
		Year Ended December 31,
		2014				2013				2012
	Provision (benefit) at statutory rate		$	1,406			$	(4,163	)		$	(6,360	)
	Permanent items			885				311				236
	State taxes			(1,228	)			210				159
	Changes in valuation allowance			(9,729	)			4,744				6,991
	Total (benefit) provision		$	(8,666	)		$	1,102			$	1,026

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	The Company is a party to certain non-cancellable operating leases for office space. The future minimum lease commitments for these leases, which expire on various dates through 2023, net of related aggregate sublease rentals, are as follows as of December 31, 2014:
	2015	$	4,042
	2016		3,782
	2017		3,532
	2018		3,328
	2019		3,419
	Thereafter		14,915
	Sublease rentals		(2,068	)
	Net lease commitments	$	30,950
Guarantees [Text Block]	The Company has entered into certain agreements with website partners, pursuant to which the Company is required to pay minimum guaranteed payments over the term of the agreement, regardless of revenue generated by the Company. Future minimum guaranteed payments as of December 31, 2014, are as follows:
	2015	$	19,095
	2016		13,934
	2017		12,257
	2018		12,135
	2019		12,322
	Thereafter		22,889
	Total	$	92,632

Supplemental_Disclosure_of_Cas1

Supplemental Disclosure of Cash Flow Information (Tables)	12 Months Ended
	Dec. 31, 2014
Supplemental Cash Flow Elements [Abstract]
Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]	Supplemental information related to the consolidated statements of cash flows is summarized below:
		Year Ended December 31,
		2014			2013			2012
	Supplemental disclosure of cash flow information:
	Interest paid		$	3,734		$	6,173		$	3,464
	Income taxes paid			341			73			55
	Supplemental disclosure of non-cash investing and financing activities:
	Issuance of common stock for acquired business		$	919		$	2,921		$	700
	Warrants issued in connection with credit facilities		$	—		$	149		$	3,452
	Warrants issued in connection with website partner agreement		$	1,131		$	—		$	—
	Capital lease obligations incurred		$	466		$	879		$	869
	Amounts due from stock option exercises		$	43		$	688		$	—

Quarterly_Financial_Data_Unaud1

Quarterly Financial Data (Unaudited) (Tables)	12 Months Ended
	Dec. 31, 2014
Quarterly Financial Information Disclosure [Abstract]
Schedule of Quarterly Financial Information [Table Text Block]	The following tables summarize the quarterly financial data for the years ended December 31, 2014 and 2013:
		2014
		First				Second				Third				Fourth
		quarter				quarter				quarter				quarter
	Revenues
	Advertising and sponsorship revenues		$	32,692			$	36,882			$	37,910			$	58,981
	Premium services revenues			4,813				4,565				4,414				4,068
	Total revenues			37,505				41,447				42,324				63,049
	Operating expenses:
	Cost of revenues			11,421				10,961				11,006				15,908
	Sales and marketing			10,220				12,216				12,213				13,956
	Product development			10,762				10,805				10,886				12,088
	General and administrative			6,595				7,126				7,504				8,816
	Total operating expenses			38,998				41,108				41,609				50,768
	Income (loss) from operations			(1,493	)			339				715				12,281
	Interest expense, net			(1,863	)			(585	)			(500	)			(763	)
	Other expense			(4,114	)			—				—				—
	Income (loss) from continuing operations before provision for income taxes			(7,470	)			(246	)			215				11,518
	Provision for income taxes			—				—				—				—
	(Loss) income from continuing operations			—				—				—				—
	Loss from discontinued operations, net of tax			—				—				—				—
	Benefit (provision) for income taxes			(289	)			(349	)			(365	)			9,669
	Net income (loss)			(7,759	)			(595	)			(150	)			21,187
	Series G preferred stock deemed dividend			—				(8,079	)			—				—
	Net income (loss) attributable to common stockholders		$	(7,759	)		$	(8,674	)		$	(150	)		$	21,187
	Basic net income (loss) attributable to common stockholders per common share:
	Net income (loss) attributable to common stockholders from continuing operations			—				—				—				—
	Net loss attributable to common stockholders from discontinued operations, net of tax			—				—				—				—
	Net income (loss) attributable to common stockholders			—				—				—				—
	Diluted net income (loss) attributable to common stockholders per common share:
	Net income (loss) attributable to common stockholders from continuing operations			—				—				—				—
	Net loss attributable to common stockholders from discontinued operations, net of tax			—				—				—				—
	Net income (loss) attributable to common stockholders			—				—				—				—
	Net income (loss) attributable to common stockholders per common share:
	Basic		$	(1.44	)		$	(0.29	)		$	(0.00	)		$	0.68
	Diluted		$	(1.44	)		$	(0.29	)		$	(0.00	)		$	0.64
	Weighted-average common shares outstanding:
	Basic			5,403,846				29,802,970				30,404,529				31,076,588
	Diluted			5,403,846				29,802,970				30,404,529				32,977,544
		2013
		First				Second				Third				Fourth
		quarter				quarter				quarter				quarter
	Revenues
	Advertising and sponsorship revenues		$	25,380			$	31,819			$	29,662			$	48,032
	Premium services revenues			5,124				5,379				5,392				5,062
	Total revenues			30,504				37,198				35,054				53,094
	Operating expenses:
	Cost of revenues			9,835				10,826				9,620				13,057
	Sales and marketing			9,061				11,860				10,814				12,650
	Product development			10,160				10,700				10,656				12,243
	General and administrative			6,539				6,191				6,462				8,270
	Total operating expenses			35,595				39,577				37,552				46,220
	(Loss) income from operations			(5,091	)			(2,379	)			(2,498	)			6,874
	Interest expense, net			(2,129	)			(2,015	)			(2,125	)			(2,173	)
	Other expense			—				—				—				(359	)
	(Loss) income from continuing operations before provision for income taxes			(7,220	)			(4,394	)			(4,623	)			4,342
	Provision for income taxes			(264	)			(247	)			(311	)			(280	)
	(Loss) income from continuing operations			(7,484	)			(4,641	)			(4,934	)			4,062
	Loss from discontinued operations, net of tax			(1,745	)			(1,596	)			(397	)			(1,501	)
	Benefit (provision) for income taxes			—				—				—				—
	Net income (loss)		$	(9,229	)		$	(6,237	)		$	(5,331	)		$	2,561
	Series G preferred stock deemed dividend			—				—				—				—
	Net income (loss) attributable to common stockholders			—				—				—				—
	Basic net income (loss) attributable to common stockholders per common share:
Net income (loss) attributable to common stockholders from continuing operations		$	(1.52	)		$	(0.92	)		$	(0.95	)		$	0.78
Net loss attributable to common stockholders from discontinued operations, net of tax			(0.35	)			(0.32	)			(0.08	)			(0.29	)
Net income (loss) attributable to common stockholders		$	(1.87	)		$	(1.24	)		$	(1.02	)		$	0.49
Diluted net income (loss) attributable to common stockholders per common share:
Net income (loss) attributable to common stockholders from continuing operations		$	(1.52	)		$	(0.92	)		$	(0.95	)		$	0.16
Net loss attributable to common stockholders from discontinued operations, net of tax			(0.35	)			(0.32	)			(0.08	)			(0.29	)
Net income (loss) attributable to common stockholders		$	(1.87	)		$	(1.24	)		$	(1.02	)		$	0.1
Net income (loss) attributable to common stockholders per common share—basic and diluted
Basic			—				—				—				—
Diluted			—				—				—				—
Weighted-average common shares outstanding:
Basic			4,925,306				5,030,265				5,213,706				5,239,463
Diluted			4,925,306				5,030,265				5,213,706				25,398,572

Significant_Accounting_Policie2

Significant Accounting Policies (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Significant Accounting Policies (Details) [Line Items]
Adjustments to additional paid-in capital warrant liability reclassified	$1,140,000
Video and TV Amortization		632,000	6,430,000
Other than Temporary Impairment Losses, Investments		1,190,000
Royalty Expense	20,937,000	18,673,000	12,898,000
Advertising Expense	24,973,000	22,437,000	23,841,000
Debtor Reorganization Items, Write-off of Deferred Financing Costs and Debt Discounts	2,845,000		1,069,000
Debt Prepayment Fees	1,016,000
Capital Units, Adjustment for Market Changes	253,000
Accounts Receivable, Gross	68,007,000	49,373,000
Unbilled Receivables, Current	7,064,000	290,000
Number of Reportable Segments	1
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in Shares)	1,337,766
DD [Member]
Significant Accounting Policies (Details) [Line Items]
Unbilled Receivables, Current	4,482
Advertising
Significant Accounting Policies (Details) [Line Items]
Unbilled Receivables, Current	2,582,000
Series G Preferred Stock [Member] | IPO [Member]
Significant Accounting Policies (Details) [Line Items]
Convertible Preferred Stock, Shares Issued upon Conversion (in Shares)	577,055
Preferred Stock [Member] | IPO [Member]
Significant Accounting Policies (Details) [Line Items]
Shares upon warrant exercises (in Shares)	222,977
Common Stock [Member] | IPO [Member]
Significant Accounting Policies (Details) [Line Items]
Shares upon warrant exercises (in Shares)	148,650
Software and Software Development Costs [Member]
Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	three
Website And Mobile Applications [Member]
Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	three
Common Stock [Member] | IPO [Member]
Significant Accounting Policies (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)	5,676,414
Convertible Preferred Stock, Shares Issued upon Conversion (in Shares)	18,457,235
Common Stock [Member]
Significant Accounting Policies (Details) [Line Items]
Stock Issued During Period, Shares, New Issues (in Shares)		330,022	105,340
IPO [Member]
Significant Accounting Policies (Details) [Line Items]
Proceeds from Issuance Initial Public Offering	70,622,000
Payments for Underwriting Expense	8,848,000
Common Stock, No Par Value (in Dollars per share)	$14
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised (in Shares)	339,053
Shares Issued Upon Warrants Exercised (in Shares)	149,839
Adjustments to additional paid-in capital warrant liability reclassified	$1,140,000
Agency | Accounts Receivable [Member] | Advertising
Significant Accounting Policies (Details) [Line Items]
Concentration Risk, Customer	10%	three
Agency1 | Accounts Receivable [Member] | Advertising
Significant Accounting Policies (Details) [Line Items]
Concentration Risk, Percentage		14.00%
Agency2 | Accounts Receivable [Member] | Advertising
Significant Accounting Policies (Details) [Line Items]
Concentration Risk, Percentage		11.00%
Agency3 | Accounts Receivable [Member] | Advertising
Significant Accounting Policies (Details) [Line Items]
Concentration Risk, Percentage		11.00%
Revenues [Member] | Advertising
Significant Accounting Policies (Details) [Line Items]
Concentration Risk, Customer	For the year ended December 31, 2014, no advertising customer accounted for greater than 10% of total revenues.	one	For the year ended December 31, 2012, no advertising customer accounted for greater than 10% of total revenues.
Concentration Risk, Percentage	10.00%	12.00%	10.00%
Accounts Receivable [Member] | Advertising
Significant Accounting Policies (Details) [Line Items]
Concentration Risk, Customer	As of December 31, 2014, no advertising customers accounted for greater than 10% of total accounts receivable.	one
Concentration Risk, Percentage	10.00%	16.00%
Minimum [Member]
Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	three
Maximum [Member]
Significant Accounting Policies (Details) [Line Items]
Property, Plant and Equipment, Estimated Useful Lives	five

Significant_Accounting_Policie3

Significant Accounting Policies (Details) - Allowance for doubtful accounts (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Allowance for doubtful accounts [Abstract]
Balance at beginning of year	$530	$651	$835
Bad debt provision	384	251	501
Write-offs	-277	-372	-685
Balance at end of year	$637	$530	$651

Significant_Accounting_Policie4

Significant Accounting Policies (Details) - Basic and diluted net income (loss) (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014		Dec. 31, 2013		Dec. 31, 2012
Numerator:
Income (loss) from continuing operations (in Dollars)					$4,062	($4,934)	($4,641)	($7,484)	$12,683		($12,997)		($19,197)
Loss from discontinued operations, net of tax (in Dollars)					-1,501	-397	-1,596	-1,745			-5,239		-3,257
Net income (loss) (in Dollars)	21,187	-150	-595	-7,759	2,561	-5,331	-6,237	-9,229	12,683		-18,236		-22,454
Series G preferred stock deemed dividend (in Dollars)			-8,079						-8,079
Net income (loss) attributable to common stockholders (in Dollars)									$4,604		($18,236)		($22,454)
Denominator:
Weighted-average number of common shares outstanding for basic net income (loss) attributable to common stockholders per common share (in Shares)	31,076,588	30,404,529	29,802,970	5,403,846	5,239,463	5,213,706	5,030,265	4,925,306	24,259,395		5,103,351		4,791,474
Warrants to purchase common stock (in Shares)									412,305
Total weighted-average diluted shares (in Shares)	32,977,544	30,404,529	29,802,970	5,403,846	25,398,572	5,213,706	5,030,265	4,925,306	26,911,782		5,103,351		4,791,474
Basic net income (loss) attributable to common stockholders per common share:
Income (loss) from continuing operations					$0.78	($0.95)	($0.92)	($1.52)	$0.19		($2.55)		($4.01)
Loss from discontinued operations, net of tax					($0.29)	($0.08)	($0.32)	($0.35)			($1.03)		($0.68)
Net income (loss) attributable to common stockholders	$0.68	$0	($0.29)	($1.44)					$0.19		($3.57)		($4.69)
Diluted net income (loss) attributable to common stockholders per common share:
Income (loss) from continuing operations					$0.16	($0.95)	($0.92)	($1.52)	$0.17		($2.55)		($4.01)
Loss from discontinued operations, net of tax					($0.29)	($0.08)	($0.32)	($0.35)			($1.03)		($0.68)
Net income (loss) attributable to common stockholders	$0.64	$0	($0.29)	($1.44)					$0.17		($3.57)		($4.69)
2014 Plan [Member]
Denominator:
Stock option awards (in Shares)									2,235,059	[1]		[1]		[1]
Employee Stock [Member]
Denominator:
Stock option awards (in Shares)									5,023
[1]	The weighted-average diluted shares for the year ended December 31, 2014 excludes a weighted-average number of stock options of 1,337,766 which were anti-dilutive.

Acquisitions_Details

Acquisitions (Details) (USD $)	3 Months Ended				12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Acquisitions (Details) [Line Items]
Income Tax Expense (Benefit)	($280)	($311)	($247)	($264)	($8,666)	$1,102	$1,026
Deferred Tax [Member] | DD [Member]
Acquisitions (Details) [Line Items]
Income Tax Expense (Benefit)					10,033
Deferred Tax [Member]
Acquisitions (Details) [Line Items]
Income Tax Expense (Benefit)					10,033
DD [Member]
Acquisitions (Details) [Line Items]
Business Acquisition, Name of Acquired Entity					DoctorDirectory.com
Business Combination, Consideration Transferred					65,000
Business Combination, Acquisition Related Costs					183
EQ [Member]
Acquisitions (Details) [Line Items]
Business Acquisition, Name of Acquired Entity							EQAL, Inc.
Business Combination, Consideration Transferred							9,657
Business Combination, Acquisition Related Costs							89
Payments to Acquire Businesses, Gross							6,736
Business Acquisition, Equity Interest Issued or Issuable, Value Assigned							2,921
Contingent Earn-out Provisions, Eligibility						5,000
Contingent Earn-out Provisions, Expense Incurred						$2,211

Acquisitions_Details_Prelimina

Acquisitions (Details) - Preliminary allocation of the assets acquired and liabilities assumed (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Acquisitions (Details) - Preliminary allocation of the assets acquired and liabilities assumed [Line Items]
Property and equipment	$25,502	$21,095
Goodwill	127,115	82,153
Intangible assets	30,716	9,735
Accounts payable and accrued expenses	31,722	34,378
Deferred tax liability	6,673	5,199
DD [Member]
Acquisitions (Details) - Preliminary allocation of the assets acquired and liabilities assumed [Line Items]
Accounts receivable	6,513
Deferred tax asset	81
Other current assets	232
Property and equipment	1,612
Goodwill	44,962
Intangible assets	23,500
Accounts payable and accrued expenses	-1,798
Deferred tax liability	-10,102
Total consideration paid	$65,000

Acquisitions_Details_Pro_forma

Acquisitions (Details) - Pro forma consolidated net sales and income from continuing operations (Pro Forma [Member], USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Pro Forma [Member]
Acquisitions (Details) - Pro forma consolidated net sales and income from continuing operations [Line Items]
Revenues	$201,335	$172,877
Net income (loss)	$4,640	($12,425)

Acquisitions_Details_Tangible_

Acquisitions (Details) - Tangible and intangible assets acquired, liabilities assumed and consideration paid (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2012	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2011
Acquisitions (Details) - Tangible and intangible assets acquired, liabilities assumed and consideration paid [Line Items]
Cash	$23,888	$50,729	$16,242	$27,238
Property and equipment		25,502	21,095
Goodwill		127,115	82,153
Intangible assets		30,716	9,735
Accounts payable and accrued expenses		31,722	34,378
Other current liabilities		965	830
EQ [Member]
Acquisitions (Details) - Tangible and intangible assets acquired, liabilities assumed and consideration paid [Line Items]
Cash	174
Accounts receivable	1,167
Other current assets	237
Property and equipment	18
Goodwill	9,904
Intangible assets	1,130
Other assets	26
Accounts payable and accrued expenses	-1,819
Deferred revenue	-625
Other current liabilities	-555
Total consideration paid	$9,657

Discontinued_Operations_Detail

Discontinued Operations (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013
Discontinued Operations and Disposal Groups [Abstract]
Proceeds from Sales of Business, Affiliate and Productive Assets		$1,000
Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax	0
Income Tax Expense (Benefit), Continuing Operations, Discontinued Operations, Extraordinary Items	$0

Discontinued_Operations_Detail1

Discontinued Operations (Details) - Loss from Discontinued Operations (USD $)	3 Months Ended								12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues	$63,049	$42,324	$41,447	$37,505	$53,094	$35,054	$37,198	$30,504	$184,325	$155,850	$138,492
Loss from operations	12,281	715	339	-1,493	6,874	-2,498	-2,379	-5,091	11,842	-3,094	-12,204
Loss from discontinued operations before tax									0
Net loss from discontinued operations										5,239	3,257
Discontinued Operations [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Revenues										7,116	7,794
Loss from operations										-3,971	-3,257
Loss on sale										-1,268
Loss from discontinued operations before tax										-5,239	-3,257
Net loss from discontinued operations										($5,239)	($3,257)

Prepaid_Expenses_and_Other_Cur2

Prepaid Expenses and Other Current Assets (Details) - Prepaid expenses and other current assets (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Prepaid Expenses And Other Current Assets [Abstract]
Prepaid royalties	$1,225	$1,195
Initial public offering costs		1,083
Prepaid marketing	422	714
Amount due from buyer of business		400
Restricted cash		500
Other	3,882	3,930
Total	$5,529	$7,822

Property_and_Equipment_Details

Property and Equipment (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Property, Plant and Equipment [Abstract]
Internally Developed Software Additions	$8,870	$7,416	$7,279
Unamortized Internally Developed Software	13,078	10,882
Internally Developed Software Amortization Expense	$6,583	$5,198	$4,196

Property_and_Equipment_Details1

Property and Equipment (Details) - Property and equipment (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Property and equipment [Abstract]
Computer equipment and purchased software	$12,402	$10,529
Internally developed software	37,226	28,486
Acquired technology	1,957	927
Furniture, fixtures and office equipment	2,978	2,858
Leasehold improvements	6,381	6,296
Website development costs	25,292	20,425
	86,236	69,521
Less accumulated depreciation and amortization	-60,734	-48,426
Total	$25,502	$21,095

Property_and_Equipment_Details2

Property and Equipment (Details) - Depreciation and amortization expense (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Depreciation and amortization expense [Abstract]
Sales and marketing	$1,286	$1,183	$1,065
Product development	10,811	10,325	9,324
General and administrative	327	350	423
Total depreciation and amortization	$12,424	$11,858	$10,812

Goodwill_and_Other_Intangible_2

Goodwill and Other Intangible Assets (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Goodwill and Other Intangible Assets (Details) [Line Items]
Goodwill	$127,115	$82,153
Finite-Lived Intangible Assets, Net	30,716	9,735
Deferred Tax Liabilities, Goodwill	-6,028	-5,066
Amortization of Intangible Assets	2,519	3,592	3,790
Customer Relationships [Member] | DD [Member]
Goodwill and Other Intangible Assets (Details) [Line Items]
Finite-Lived Intangible Assets, Net	15,390
Finite-Lived Intangible Asset, Useful Life	10 years
Customer Relationships [Member]
Goodwill and Other Intangible Assets (Details) [Line Items]
Finite-Lived Intangible Assets, Net	16,053	1,429
Trade Names [Member] | DD [Member]
Goodwill and Other Intangible Assets (Details) [Line Items]
Finite-Lived Intangible Assets, Net	8,110
Finite-Lived Intangible Asset, Useful Life	7 years
Trade Names [Member]
Goodwill and Other Intangible Assets (Details) [Line Items]
Finite-Lived Intangible Assets, Net	14,245	7,331
DD [Member]
Goodwill and Other Intangible Assets (Details) [Line Items]
Goodwill	44,962
Finite-Lived Intangible Assets, Net	23,500
Deferred Tax Liabilities, Goodwill	10,033
EQ [Member]
Goodwill and Other Intangible Assets (Details) [Line Items]
Goodwill			9,904
Finite-Lived Intangible Assets, Net			1,130
Goodwill, Period Increase (Decrease)		321
Preliminary Goodwill			9,583
DoctorSolutions
Goodwill and Other Intangible Assets (Details) [Line Items]
Goodwill, Written off Related to Sale of Business Unit		235
Indefinite-lived Intangible Assets, Written off Related to Sale of Business Unit		$1,547

Goodwill_and_Other_Intangible_3

Goodwill and Other Intangible Assets (Details) - Schedule of definite-lived intangible assets (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014		Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$49,815		$26,315
Accumulated amortization	-19,099		-16,580
Net carrying amount	30,716		9,735
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	27,300		11,910
Accumulated amortization	-11,247		-10,481
Net carrying amount	16,053		1,429
Weighted- average remaining useful life	9 years 6 months	[1]	2 years 328 days	[1]
Other Intangible Assets [Member]
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	3,900		3,900
Accumulated amortization	-3,482		-2,925
Net carrying amount	418		975
Weighted- average remaining useful life	255 days	[1]	1 year 255 days	[1]
Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	18,615		10,505
Accumulated amortization	-4,370		-3,174
Net carrying amount	$14,245		$7,331
Weighted- average remaining useful life	6 years 6 months	[1]	7 years	[1]
[1]	The calculation of the weighted-average remaining useful life is based on weighting the net book value of each asset in its group, and applying the weight to its respective remaining amortization period.

Goodwill_and_Other_Intangible_4

Goodwill and Other Intangible Assets (Details) - Schedule of future amortization expense of intangible assets (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Schedule of future amortization expense of intangible assets [Abstract]
2015	$4,635
2016	3,945
2017	3,937
2018	3,748
2019	3,748
Thereafter	10,703
Total	$30,716	$9,735

Accounts_Payable_and_Accrued_E2

Accounts Payable and Accrued Expenses (Details) - Accrued expenses (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Accrued expenses [Abstract]
Accounts payable	$8,563	$8,459
Accrued compensation	8,260	8,282
Accrued acquisition earn-outs	1,425	3,639
Accrued royalties	5,991	6,589
Accrued media and licensed content	3,716	3,178
Accrued interest	408	943
Accrued professional fees	718	872
Other accrued expenses	2,641	2,416
Total	$31,722	$34,378

LongTerm_Debt_Details

Long-Term Debt (Details) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Mar. 31, 2014	Nov. 30, 2014	Nov. 01, 2014
Long-Term Debt (Details) [Line Items]
Credit Facility Rate Description	The interest rate on the Credit Facility is equal to the London Inter-Bank Offered Rate, or LIBOR, plus a variable rate ranging from 2.75% to 4.0% depending on the Company’s consolidated leverage ratio, as defined in the Credit Facility agreement, and there is a 0.50% commitment fee on the unused portion of the Revolver.
Line of Credit Facility, Maximum Borrowing Capacity of Eligible Accounts Receivable		80.00%
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)	$0.02
Adjustments to additional paid-in capital warrant liability reclassified	$1,140
Payments of Financing Costs	2,899	68	1,345
Amortization of Financing Costs	528	1,646	687
Common Stock [Member] | IPO [Member]
Long-Term Debt (Details) [Line Items]
Shares upon warrant exercises (in Shares)	148,650
Common Stock [Member] | Former credit facility [Member]
Long-Term Debt (Details) [Line Items]
Shares upon warrant exercises (in Shares)	592,501
Series F Preferred Stock [Member] | Former credit facility [Member]
Long-Term Debt (Details) [Line Items]
Shares upon warrant exercises (in Shares)	112,959
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)	$7.61
Series C Preferred Stock [Member] | Former credit facility [Member]
Long-Term Debt (Details) [Line Items]
Shares upon warrant exercises (in Shares)	110,018
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)	$3.27
Preferred Stock [Member] | IPO [Member]
Long-Term Debt (Details) [Line Items]
Shares upon warrant exercises (in Shares)	222,977
IPO [Member]
Long-Term Debt (Details) [Line Items]
Adjustments to additional paid-in capital warrant liability reclassified	1,140
Former Revolver [Member] | Minimum [Member]
Long-Term Debt (Details) [Line Items]
Debt Instrument, Basis Spread on Variable Rate		2.00%
Former Revolver [Member] | Maximum [Member]
Long-Term Debt (Details) [Line Items]
Credit Facility Rate Monthly		5.25%
Former Revolver [Member]
Long-Term Debt (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity					35,000
Line of Credit Facility, Fair Value of Amount Outstanding		30,000
Former Term Loan [Member] | Minimum [Member]
Long-Term Debt (Details) [Line Items]
Debt Instrument, Basis Spread on Variable Rate		3.25%
Former Term Loan [Member] | Maximum [Member]
Long-Term Debt (Details) [Line Items]
Credit Facility Rate Monthly		6.50%
Former Term Loan [Member]
Long-Term Debt (Details) [Line Items]
Credit Facility Maximum Borrowing Capacity		1,333			40,000
Revolving Credit Facility [Member] | DD [Member]
Long-Term Debt (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity						55,000
Revolving Credit Facility [Member]
Long-Term Debt (Details) [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity		30,000
Line of Credit Facility, Unused Capacity, Commitment Fee Percentage	0.50%
Line of Credit Facility, Fair Value of Amount Outstanding	30,000
Term Loan Facility [Member] | DD [Member]
Long-Term Debt (Details) [Line Items]
Credit Facility Maximum Borrowing Capacity						60,000
Credit Facility, Outstanding Balance							39,000
Term Loan Facility [Member]
Long-Term Debt (Details) [Line Items]
Credit Facility Maximum Borrowing Capacity		8,500
Credit Facility, Outstanding Balance	60,000
Credit Facility Increases Decreases		5,000
Credit Facility [Member] | Minimum [Member]
Long-Term Debt (Details) [Line Items]
Credit Facility Rate Monthly	2.75%
Credit Facility [Member] | Maximum [Member]
Long-Term Debt (Details) [Line Items]
Credit Facility Rate Monthly	4.00%
Credit Facility [Member]
Long-Term Debt (Details) [Line Items]
Credit Facility Rate Monthly	3.48%
Former credit facility [Member]
Long-Term Debt (Details) [Line Items]
Credit Facility Maximum Borrowing Capacity				15,000
Credit Facility Rate Monthly				13.00%
Write off of Deferred Debt Issuance Cost	2,845
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)	$0.02
Prepayment Fees [Member]
Long-Term Debt (Details) [Line Items]
Write off of Deferred Debt Issuance Cost	1,016
Subordinated Facility [Member]
Long-Term Debt (Details) [Line Items]
Credit Facility Maximum Borrowing Capacity			35,000
Credit Facility, Outstanding Balance		$40,000
Credit Facility Rate Monthly			14.00%

LongTerm_Debt_Details_Long_Ter

Long-Term Debt (Details) - Long Term Debt (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified
Long-term Debt, Unclassified [Abstract]
2015	$3,000
2016	6,000
2017	6,000
2018	6,000
2019	69,000
Total	$90,000

Common_Stock_and_Redeemable_Co2

Common Stock and Redeemable Convertible Preferred Stock (Details) (USD $)	3 Months Ended	12 Months Ended	16 Months Ended	1 Months Ended
	Mar. 31, 2014	Dec. 31, 2014	Apr. 30, 2014	Apr. 30, 2014	Dec. 31, 2013
Common Stock and Redeemable Convertible Preferred Stock (Details) [Line Items]
Preferred Stock, Shares Issued		0			26,820,270
Preferred Stock, Shares Outstanding		0			26,820,270
Shares Issued, Price Per Share (in Dollars per share)			$14	$14
Dividends, Preferred Stock (in Dollars)		$0
Redeemable Preferred Stock Voting Rights			Each holder of Preferred Stock was entitled to the number of votes equal to the number of shares of common stock into which such holder’s shares of Preferred Stock were convertible at the time of such vote and would vote together with the holders of common stock on any matters presented to the stockholders for their consideration. In addition, the holders of Preferred Stock were entitled to vote separately from the common stock to elect six members of the Board of Directors and to approve certain specified matters. On all matters in which the holders of Preferred Stock were entitled to vote separately, the holders of Series E could not cast more than 28.5% of the votes (the “Series E Reduced Voting”).
Preferred Stock, Redemption Terms			Redemption rights issued in connection with the Series C were extended to the holders of the Series A and Series B in February 2006, with the right to require redemption commencing 60 days after receipt by the Company of a notice by the holders of Preferred Stock on or after February 2011. Redemption rights were also issued to the holders of the Series D, with the right to require redemption commencing 60 days after receipt by the Company of a notice by the holders of Preferred Stock on or after August 2012.
Stockholders' Equity, Reverse Stock Split	In March 2014, the Company’s Board of Directors and stockholders approved an amendment to the Company’s amended and restated certificate of incorporation effecting a 1-for-1.5 reverse stock split of the Company’s issued and outstanding shares of common stock. The par value of the common stock was not adjusted as a result of the reverse stock split. All issued and outstanding common stock and per share amounts contained in the Company’s consolidated financial statements and related notes thereto have been retroactively adjusted to reflect this reverse stock split for all periods presented. The reverse stock split was effected on March 14, 2014.
Common Stock, Shares Authorized		90,000,000	90,000,000	90,000,000	45,000,000
Preferred Stock, Shares Authorized		10,000,000	10,000,000	10,000,000	27,204,144
Temporary Equity, Shares Outstanding					26,820,270
Conversion Price IPO Adjustment Threshold (in Dollars per share)			$11.88	$11.88
Preferred Stock, Redemption Price Per Share (in Dollars per share)			$14	$14
Class of Warrant or Right, Outstanding		100,000
Class of Warrant or Right, Exercise Price of Warrants or Rights (in Dollars per share)		$0.02
Deferred Costs and Other Assets (in Dollars)		1,131,000
Series A Preferred Stock [Member]
Common Stock and Redeemable Convertible Preferred Stock (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)					0.5
Preferred Stock, Shares Authorized					3,450,000
Temporary Equity, Shares Outstanding					3,450,000
Series B Preferred Stock [Member]
Common Stock and Redeemable Convertible Preferred Stock (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)					1.77
Preferred Stock, Shares Authorized					2,547,252
Temporary Equity, Shares Outstanding					2,547,252
Series C Preferred Stock [Member] | Maximum [Member]
Common Stock and Redeemable Convertible Preferred Stock (Details) [Line Items]
Preferred Stock, Liquidation Preference Per Share (in Dollars per share)			$6.54	$6.54
Series C Preferred Stock [Member]
Common Stock and Redeemable Convertible Preferred Stock (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)					3.27
Preferred Stock, Shares Authorized					1,943,651
Temporary Equity, Shares Outstanding					1,833,633
Series D Preferred Stock [Member] | Maximum [Member]
Common Stock and Redeemable Convertible Preferred Stock (Details) [Line Items]
Preferred Stock, Liquidation Preference Per Share (in Dollars per share)			$10.30	$10.30
Series D Preferred Stock [Member]
Common Stock and Redeemable Convertible Preferred Stock (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)					6.87
Preferred Stock, Shares Authorized					3,934,855
Temporary Equity, Shares Outstanding					3,934,855
Series E Preferred Stock [Member]
Common Stock and Redeemable Convertible Preferred Stock (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)					7.98
Liquidation Value Preferred Stock (in Dollars)			1.77
Redeemable Preferred Stock Voting Rights			On all matters in which the holders of Preferred Stock were entitled to vote separately, the holders of Series E could not cast more than 28.5% of the votes (the “Series E Reduced Voting”).
Preferred Stock, Shares Authorized					8,930,966
Temporary Equity, Shares Outstanding					8,930,966
Series F Preferred Stock [Member]
Common Stock and Redeemable Convertible Preferred Stock (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)					7.61
Preferred Stock, Shares Authorized					3,064,087
Temporary Equity, Shares Outstanding					2,951,128
Series G Preferred Stock [Member] | Effect of 1-for-1.5 stock split [Member]
Common Stock and Redeemable Convertible Preferred Stock (Details) [Line Items]
Conversion Price IPO Adjustment Increased Price (in Dollars per share)			$17.82	$17.82
Series G Preferred Stock [Member] | Ratchet Provision Deemed Dividend [Member]
Common Stock and Redeemable Convertible Preferred Stock (Details) [Line Items]
Dividends, Stock (in Dollars)				8,079,000
Series G Preferred Stock [Member] | Maximum [Member]
Common Stock and Redeemable Convertible Preferred Stock (Details) [Line Items]
Liquidation Value Preferred Stock (in Dollars)			$12.15
Series G Preferred Stock [Member]
Common Stock and Redeemable Convertible Preferred Stock (Details) [Line Items]
Shares Issued, Price Per Share (in Dollars per share)					9
Fixed Interest Per Annum (in Dollars per share)			$0.90
Interest for unredeemed shares			15.00%
Preferred Stock, Shares Authorized					3,333,333
Temporary Equity, Shares Outstanding			3,172,436	3,172,436	3,172,436
Stock Issued During Period, Shares, Conversion of Convertible Securities		2,692,012
Series A, B, C, D, E, F [Member]
Common Stock and Redeemable Convertible Preferred Stock (Details) [Line Items]
Temporary Equity, Shares Outstanding			23,647,834	23,647,834
Stock Issued During Period, Shares, Conversion of Convertible Securities		15,765,223
2003 Stock Option Plan [Member]
Common Stock and Redeemable Convertible Preferred Stock (Details) [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance		0
2014 Stock Option Plan [Member]
Common Stock and Redeemable Convertible Preferred Stock (Details) [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance		347,371
Employee Stock [Member]
Common Stock and Redeemable Convertible Preferred Stock (Details) [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance		361,816
Ratchet Provision [Member]
Common Stock and Redeemable Convertible Preferred Stock (Details) [Line Items]
Incremental Common Shares Attributable to Dilutive Effect of Conversion of Preferred Stock				577,055

Common_Stock_and_Redeemable_Co3

Common Stock and Redeemable Convertible Preferred Stock (Details) - Schedule of redeemable convertible preferred stock (USD $)	Dec. 31, 2014	Apr. 30, 2014	Dec. 31, 2013
In Thousands, except Share data, unless otherwise specified
Redeemable convertible preferred stock:
Redeemable convertible preferred stock, Shares Authorized	10,000,000	10,000,000	27,204,144
Redeemable convertible preferred stock, Shares Issued and Oustanding			26,820,270
Redeemable convertible preferred stock, Stated Value, net of expenses			$158,766
Redeemable convertible preferred stock, Liquidation Preferences			114,627
Series A Preferred Stock [Member]
Redeemable convertible preferred stock:
Redeemable convertible preferred stock, Shares Authorized			3,450,000
Redeemable convertible preferred stock, Shares Issued and Oustanding			3,450,000
Redeemable convertible preferred stock, Stated Value, net of expenses			1,053
Redeemable convertible preferred stock, Liquidation Preferences			1,725
Series B Preferred Stock [Member]
Redeemable convertible preferred stock:
Redeemable convertible preferred stock, Shares Authorized			2,547,252
Redeemable convertible preferred stock, Shares Issued and Oustanding			2,547,252
Redeemable convertible preferred stock, Stated Value, net of expenses			4,413
Redeemable convertible preferred stock, Liquidation Preferences			4,500
Series C Preferred Stock [Member]
Redeemable convertible preferred stock:
Redeemable convertible preferred stock, Shares Authorized			1,943,651
Redeemable convertible preferred stock, Shares Issued and Oustanding			1,833,633
Redeemable convertible preferred stock, Stated Value, net of expenses			5,882
Redeemable convertible preferred stock, Liquidation Preferences			6,000
Series D Preferred Stock [Member]
Redeemable convertible preferred stock:
Redeemable convertible preferred stock, Shares Authorized			3,934,855
Redeemable convertible preferred stock, Shares Issued and Oustanding			3,934,855
Redeemable convertible preferred stock, Stated Value, net of expenses			25,354
Redeemable convertible preferred stock, Liquidation Preferences			27,027
Series E Preferred Stock [Member]
Redeemable convertible preferred stock:
Redeemable convertible preferred stock, Shares Authorized			8,930,966
Redeemable convertible preferred stock, Shares Issued and Oustanding			8,930,966
Redeemable convertible preferred stock, Stated Value, net of expenses			71,250
Redeemable convertible preferred stock, Liquidation Preferences			15,789
Series F Preferred Stock [Member]
Redeemable convertible preferred stock:
Redeemable convertible preferred stock, Shares Authorized			3,064,087
Redeemable convertible preferred stock, Shares Issued and Oustanding			2,951,128
Redeemable convertible preferred stock, Stated Value, net of expenses			22,468
Redeemable convertible preferred stock, Liquidation Preferences			22,468
Series G Preferred Stock [Member]
Redeemable convertible preferred stock:
Redeemable convertible preferred stock, Shares Authorized			3,333,333
Redeemable convertible preferred stock, Shares Issued and Oustanding		3,172,436	3,172,436
Redeemable convertible preferred stock, Stated Value, net of expenses			28,346
Redeemable convertible preferred stock, Liquidation Preferences			$37,118

StockBased_Compensation_Detail

Stock-Based Compensation (Details) (USD $)	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Apr. 30, 2014	Mar. 27, 2014
Stock-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value	$8,080	$1,146	$218
Proceeds from Stock Options Exercised	7,939	101	168
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in Dollars per share)	$7.53	$4.80	$3.32
Allocated Share-based Compensation Expense	7,920	3,039	3,610
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options	6,902
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition	1 year 105 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value	4,328	3,668	3,014
Common Stock, Shares Authorized (in Shares)	90,000,000	45,000,000		90,000,000
Stock Issued During Period, Value, Employee Stock Purchase Plan	1,592
Discontinued Operations [Member]
Stock-Based Compensation (Details) [Line Items]
Allocated Share-based Compensation Expense	0	70	78
Performance Shares [Member]
Stock-Based Compensation (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in Shares)	112,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares (in Shares)	90,555
Stock Issued During Period, Shares, Share-based Compensation, Forfeited (in Shares)	21,945
2014 Plan [Member]
Stock-Based Compensation (Details) [Line Items]
Common stock, aggregate shares issued, description	The aggregate number of shares of the Company’s common stock that may be issued pursuant to the 2014 Plan is the sum of (1) 200,000 shares, (2) the 388,781 shares reserved for issuance under the 2003 Plan at the time the 2014 Plan became effective, and (3) any shares subject to outstanding stock options that would otherwise have returned to the 2003 Plan (such as upon the expiration or termination of stock options prior to vesting).
Common stock, number of shares reserved for issuance, description	In addition, the number of shares of common stock reserved for issuance under the 2014 Plan will automatically increase on January 1 of each year from January 1, 2015 through January 1, 2024 by the lesser of (a) 4% of the total number of shares of the Company’s common stock outstanding on December 31 of the preceding calendar year and (b) a number of shares determined by the Board of Directors.
Common Stock, Capital Shares Reserved for Future Issuance (in Shares)	347,371
Employee Stock [Member]
Stock-Based Compensation (Details) [Line Items]
Common stock, number of shares reserved for issuance, description	The number of shares of common stock reserved for issuance under the ESPP will automatically increase on January 1 of each calendar year from January 1, 2015 through January 1, 2024 by the least of (a) 1% of the total number of shares of common stock outstanding on December 31 of the preceding calendar year, (b) 400,000 shares and (c) a number determined by the Board of Directors that is less than (a) and (b).
Common Stock, Capital Shares Reserved for Future Issuance (in Shares)	361,816
Allocated Share-based Compensation Expense	1,180
Common Stock, Shares Authorized (in Shares)					500,000
Common stock, purchase for participating employee price, description	Unless otherwise determined by the Board of Directors, common stock will be purchased for participating employees at a price per share equal to the lower of (a) 85% of the fair market value of a share of the common stock on the first date of an offering, or (b) 85% of the fair market value of a share of the common stock on the date of purchase.
Contribution Percentage	15.00%
Stock Issued During Period, Shares, Employee Stock Purchase Plans (in Shares)	138,184
Stock Issued During Period, Value, Employee Stock Purchase Plan	$1,592

StockBased_Compensation_Detail1

Stock-Based Compensation (Details) - Schedule of stock option activity (Stock Option Activity [Member], USD $)	0 Months Ended	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Stock Option Activity [Member]
Stock-Based Compensation (Details) - Schedule of stock option activity [Line Items]
Outstanding, Number of options	4,163,677	5,893,698	5,457,791	5,271,707	4,163,677
Outstanding, Weighted-average exercise price	$7.43	$9.94	$7.61	$7.28	$7.43
Outstanding, Weighted-average remaining contractual life	7 years 3 months	6 years 175 days	6 years 197 days	7 years 3 days
Outstanding, Aggregate intrinsic value	$3,194	$29,249	$20,396	$10,556	$3,194
Exercisable at December 31, 2014		3,556,287
Exercisable at December 31, 2014		$7.84
Exercisable at December 31, 2014		4 years 328 days
Exercisable at December 31, 2014		$24,731
Granted, Number of options		1,945,851	901,476	1,453,961
Granted, Weighted-average exercise price		$14.67	$9.41	$6.78
Exercised, Number of options		-1,139,891	-183,501	-46,505
Exercised, Weighted-average exercise price		$6.41	$4.31	$3.62
Cancelled, Number of options		-370,053	-531,891	-299,426
Cancelled, Weighted-average exercise price		$10.52	$7.67	$8.36

StockBased_Compensation_Detail2

Stock-Based Compensation (Details) - Schedule of weighted-average assumptions (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Schedule of weighted-average assumptions [Abstract]
Volatility	49.28%	50.32%	49.50%
Expected life (years)	6 years 3 months	6 years 3 months	6 years 3 months
Risk-free interest rate	1.92%	1.54%	1.23%
Dividend yield (in Dollars per share)	$0	$0	$0

Income_Taxes_Details

Income Taxes (Details) (USD $)	3 Months Ended				12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Taxes (Details) [Line Items]
Income Tax Expense (Benefit)	($280)	($311)	($247)	($264)	($8,666)	$1,102	$1,026
Deferred Tax Liabilities Increase (Decrease)					951
Operating Loss Carryforwards					107,000
Deferred Tax [Member] | DD [Member]
Income Taxes (Details) [Line Items]
Income Tax Expense (Benefit)					10,033
Deferred Tax [Member]
Income Taxes (Details) [Line Items]
Income Tax Expense (Benefit)					10,033
Deferred Compensation, Share-based Payments [Member]
Income Taxes (Details) [Line Items]
Operating Loss Carryforwards					$7,433

Income_Taxes_Details_Provision

Income Taxes (Details) - Provision (benefit) from continuing operations for income taxes (USD $)	3 Months Ended				12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Provision (benefit) from continuing operations for income taxes [Abstract]
Federal					$250
State					110	95	62
Foreign					45	45	33
Total current					405	140	95
Federal					-7,058	749	749
State					-2,013	213	182
Total deferred					-9,071	962	931
Total	($280)	($311)	($247)	($264)	($8,666)	$1,102	$1,026

Income_Taxes_Details_Deferred_

Income Taxes (Details) - Deferred tax assets (liabilities) (USD $)	Dec. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Deferred tax assets (liabilities) [Abstract]
Net operating loss carryforwards	$40,899	$44,856
Allowance for doubtful accounts	258	148
Intangible and other assets	1,595	1,569
Deferred revenue	190	304
Stock-based compensation	9,504	7,886
Accrued expenses and other	4,038	4,348
AMT credit	250
Depreciation	1,722	530
Total deferred tax assets	58,456	59,641
Valuation allowance	-46,577	-57,169
Net deferred tax assets	11,879	2,472
Depreciation	-69
Goodwill	-6,028	-5,066
Intangible and other assets	-11,799	-2,472
Total deferred tax liabilities	-17,896	-7,538
Net deferred tax liabilities	($6,017)	($5,066)

Income_Taxes_Details_Reconcila

Income Taxes (Details) - Reconcilation Between Statutory and Effective Tax Rate (USD $)	3 Months Ended				12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Reconcilation Between Statutory and Effective Tax Rate [Abstract]
Provision (benefit) at statutory rate					$1,406	($4,163)	($6,360)
Permanent items					885	311	236
State taxes					-1,228	210	159
Changes in valuation allowance					-9,729	4,744	6,991
Total (benefit) provision	($280)	($311)	($247)	($264)	($8,666)	$1,102	$1,026

Commitments_and_Contingencies_1

Commitments and Contingencies (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Commitments and Contingencies Disclosure [Abstract]
Operating Leases, Rent Expense, Net	$3,625	$3,377	$3,009
Operating Leases, Rent Expense, Sublease Rentals	$427	$102	$78

Commitments_and_Contingencies_2

Commitments and Contingencies (Details) - Operating Leases (USD $)	Dec. 31, 2014
In Thousands, unless otherwise specified
Operating Leases [Abstract]
2015	$4,042
2016	3,782
2017	3,532
2018	3,328
2019	3,419
Thereafter	14,915
Sublease rentals	-2,068
Net lease commitments	$30,950

Commitments_and_Contingencies_3

Commitments and Contingencies (Details) - Minimum Guaranteed Payments (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014
Minimum Guaranteed Payments [Abstract]
2015	$19,095
2016	13,934
2017	12,257
2018	12,135
2019	12,322
Thereafter	22,889
Total	$92,632

Benefit_Plan_Details

Benefit Plan (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Compensation and Retirement Disclosure [Abstract]
Defined Contribution Plan, Employer Discretionary Contribution Amount	$487	$409	$339

RelatedParty_Transactions_Deta

Related-Party Transactions (Details) (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Consulting Firm [Member]
Related-Party Transactions (Details) [Line Items]
Costs and Expenses, Related Party	$142	$554
Financial Advisory Firm [Member]
Related-Party Transactions (Details) [Line Items]
Costs and Expenses, Related Party		$630

Supplemental_Disclosure_of_Cas2

Supplemental Disclosure of Cash Flow Information (Details) - Supplemental Disclosure of Cash Flow Information (USD $)	12 Months Ended
In Thousands, unless otherwise specified	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Supplemental disclosure of non-cash investing and financing activities:
Issuance of common stock for acquired business	$919
Warrants issued in connection with credit facilities		149	3,452
Warrants issued in connection with website partner agreement	1,131
Supplemental [Member]
Supplemental disclosure of cash flow information:
Interest paid	3,734	6,173	3,464
Income taxes paid	341	73	55
Supplemental disclosure of non-cash investing and financing activities:
Issuance of common stock for acquired business	919	2,921	700
Warrants issued in connection with credit facilities		149	3,452
Warrants issued in connection with website partner agreement	1,131
Capital lease obligations incurred	466	879	869
Amounts due from stock option exercises	$43	$688

Quarterly_Financial_Data_Unaud2

Quarterly Financial Data (Unaudited) (Details) - Quarterly financial data (USD $)	3 Months Ended								12 Months Ended
In Thousands, except Share data, unless otherwise specified	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Quarterly Financial Data [Abstract]
Advertising and sponsorship revenues	$58,981	$37,910	$36,882	$32,692	$48,032	$29,662	$31,819	$25,380	$166,465	$134,893	$109,956
Premium services revenues	4,068	4,414	4,565	4,813	5,062	5,392	5,379	5,124	17,860	20,957	23,536
Total revenues	63,049	42,324	41,447	37,505	53,094	35,054	37,198	30,504	184,325	155,850	138,492
Cost of revenues	15,908	11,006	10,961	11,421	13,057	9,620	10,826	9,835	49,296	43,338	40,543
Sales and marketing	13,956	12,213	12,216	10,220	12,650	10,814	11,860	9,061	48,605	44,385	38,603
Product development	12,088	10,886	10,805	10,762	12,243	10,656	10,700	10,160
General and administrative	8,816	7,504	7,126	6,595	8,270	6,462	6,191	6,539	30,041	27,462	25,874
Total operating expenses	50,768	41,609	41,108	38,998	46,220	37,552	39,577	35,595	172,483	158,944	150,696
Income (loss) from operations	12,281	715	339	-1,493	6,874	-2,498	-2,379	-5,091	11,842	-3,094	-12,204
Interest expense, net	-763	-500	-585	-1,863	-2,173	-2,125	-2,015	-2,129	-3,711	-8,442	-4,898
Other expense				-4,114	-359				-4,114	-359	-1,069
Income (loss) from continuing operations before provision for income taxes	11,518	215	-246	-7,470	4,342	-4,623	-4,394	-7,220	4,017	-11,895	-18,171
Provision for income taxes					-280	-311	-247	-264	-8,666	1,102	1,026
(Loss) income from continuing operations					4,062	-4,934	-4,641	-7,484	12,683	-12,997	-19,197
Loss from discontinued operations, net of tax					-1,501	-397	-1,596	-1,745		-5,239	-3,257
Benefit (provision) for income taxes	9,669	-365	-349	-289
Net income (loss)	21,187	-150	-595	-7,759	2,561	-5,331	-6,237	-9,229	12,683	-18,236	-22,454
Series G preferred stock deemed dividend			-8,079						-8,079
Net income (loss) attributable to common stockholders	$21,187	($150)	($8,674)	($7,759)
Basic net income (loss) attributable to common stockholders per common share:
Net income (loss) attributable to common stockholders from continuing operations (in Dollars per share)					$0.78	($0.95)	($0.92)	($1.52)	$0.19	($2.55)	($4.01)
Net loss attributable to common stockholders from discontinued operations, net of tax (in Dollars per share)					($0.29)	($0.08)	($0.32)	($0.35)		($1.03)	($0.68)
Net income (loss) attributable to common stockholders (in Dollars per share)					$0.49	($1.02)	($1.24)	($1.87)
Diluted net income (loss) attributable to common stockholders per common share:
Net income (loss) attributable to common stockholders from continuing operations (in Dollars per share)					$0.16	($0.95)	($0.92)	($1.52)	$0.17	($2.55)	($4.01)
Net loss attributable to common stockholders from discontinued operations, net of tax (in Dollars per share)					($0.29)	($0.08)	($0.32)	($0.35)		($1.03)	($0.68)
Net income (loss) attributable to common stockholders (in Dollars per share)					$0.10	($1.02)	($1.24)	($1.87)
Basic (in Dollars per share)	$0.68	$0	($0.29)	($1.44)					$0.19	($3.57)	($4.69)
Diluted (in Dollars per share)	$0.64	$0	($0.29)	($1.44)					$0.17	($3.57)	($4.69)
Basic (in Shares)	31,076,588	30,404,529	29,802,970	5,403,846	5,239,463	5,213,706	5,030,265	4,925,306	24,259,395	5,103,351	4,791,474
Diluted (in Shares)	32,977,544	30,404,529	29,802,970	5,403,846	25,398,572	5,213,706	5,030,265	4,925,306	26,911,782	5,103,351	4,791,474